{"content":"<li class=\"n-box-item date-title\" data-end=\"1506571199\" data-start=\"1506484800\" data-txt=\"Monday, December 23, 2019\">Wednesday, September 27, 2017</li><li class=\"n-box-item sa-box-item\" data-id=\"3298045\" data-ts=\"1506556220\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VZ\" target=\"_blank\">VZ</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3298045-morningstar-smaller-firms-setting-rules-in-undervalued-u-s-wireless\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Morningstar: Smaller firms setting rules in &#39;undervalued&#39; U.S. wireless</a></h4><ul>   <li>Morningstar says that the smaller players in U.S. wireless (but particularly T-Mobile (<a href=\"http://seekingalpha.com/symbol/TMUS\" target=\"_blank\">TMUS</a> <font color='red'>-1%</font>)) are setting the rules in a market it still considers <a href=\"http://news.morningstar.com/articlenet/article.aspx?id=826128&amp;SR=Yahoo&amp;yptr=yahoo\" target=\"_blank\">modestly undervalued amid hot competition</a>.</li>    <li>Verizon (NYSE:<a href='https://seekingalpha.com/symbol/VZ' title='Verizon Communications'>VZ</a>) is still the leader, but it and duopoly partner AT&amp;T (<a href=\"http://seekingalpha.com/symbol/T\" target=\"_blank\">T</a> <font color='green'>+0.1%</font>) are being \"undermined at the margin\" by T-Mobile and Sprint (<a href=\"http://seekingalpha.com/symbol/S\" target=\"_blank\">S</a> <font color='red'>-0.5%</font>), \"and we don't see this trend slowing anytime soon,\" writes Brian Colello.</li>    <li>Verizon's ability to command premium pricing is going to continue to decrease, he suggests, constraining expansion of its future returns.</li>    <li>Meanwhile, AT&amp;T \"paid a rich price\" for DirecTV, an asset the firm believes offers minimal benefits to the core telecom business.</li>    <li>\"T-Mobile is the only large U.S. carrier that is increasing wireless service revenue,\" Colello says, \"and while we doubt it can keep increasing wireless service revenue in the double digits, mid-single-digit growth appears achievable, versus declining revenue for the industry as a whole.\"</li>    <li>Morningstar considers AT&amp;T, Verizon and T-Mobile to be near fairly valued, and Sprint \"significantly overvalued.\"</li>    <li>Elsewhere, it says the French telecom market is stabilizing after a splashy entrance from low-cost carrier Iliad (<a href=\"http://seekingalpha.com/symbol/ILIAY\" target=\"_blank\">ILIAY</a> <font color='red'>-2%</font>); Orange (<a href=\"http://seekingalpha.com/symbol/ORAN\" target=\"_blank\">ORAN</a> <font color='red'>-0.1%</font>) and SFR (<a href='https://seekingalpha.com/symbol/NUMCF' title='SFR Group SA'>OTCPK:NUMCF</a>) have \"narrow economic moats due to cost advantages and efficient scale.\"</li> </ul><div class=\"tiny-share-widget\" data-id=\"3298045\" data-linked=\"Morningstar: Smaller firms setting rules in &#39;undervalued&#39; U.S. wireless\" data-tweet=\"$VZ $VZ $NUMCF - Morningstar: Smaller firms setting rules in &#39;undervalued&#39; U.S. wireless https://seekingalpha.com/news/3298045-morningstar-smaller-firms-setting-rules-in-undervalued-u-s-wireless?source=tweet\" data-url=\"https://seekingalpha.com/news/3298045-morningstar-smaller-firms-setting-rules-in-undervalued-u-s-wireless\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:50 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>81&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3298040\" data-ts=\"1506553085\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TI\" target=\"_blank\">TI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3298040-official-vivendi-didnt-come-up-france-italy-summit\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Official: Vivendi didn&#39;t come up at France-Italy summit</a></h4><ul>   <li>France's Vivendi (<a href=\"http://seekingalpha.com/symbol/VIVHY\" target=\"_blank\">VIVHY</a> <font color='red'>-0.2%</font>) is facing Italian sanctions (including a <a href=\"https://seekingalpha.com/news/3297158-reuters-italy-ready-fine-vivendi-300m\" target=\"_blank\">fine of up to &euro;300M</a>) over its involvement with Telecom Italia (<a href='https://seekingalpha.com/symbol/TI' title='Telecom Italia S.P.A.'>TI</a>  <font color='green'>+1.6%</font>), but the <a href=\"https://finance.yahoo.com/news/vivendis-role-telecom-italia-not-180026041.html\" target=\"_blank\">subject didn't come up</a> at a summit today between the governments of the two countries, an Italian official says.</li>    <li>\"I never even raised the issue,\" says Italy's Industry Minister Carlo Calenda.</li>    <li>The Vivendi-TI question hinges on whether the French media giant has de facto control of Telecom Italia, which Italy's government may consider to have national strategic value. Vivendi has a 24% holding in TI.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3298040\" data-linked=\"Official: Vivendi didn&#39;t come up at France-Italy summit\" data-tweet=\"$TI $TI $VIVHY - Official: Vivendi didn&#39;t come up at France-Italy summit https://seekingalpha.com/news/3298040-official-vivendi-didnt-come-up-france-italy-summit?source=tweet\" data-url=\"https://seekingalpha.com/news/3298040-official-vivendi-didnt-come-up-france-italy-summit\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:58 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3298038\" data-ts=\"1506551556\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WIN\" target=\"_blank\">WIN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3298038-windstream-rebounds-5-firms-debate-bond-default-claim\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Windstream rebounds 5% as firms debate bond-default claim</a></h4><ul>   <li>Shares in Windstream Holdings (NASDAQ:<a href='https://seekingalpha.com/symbol/WIN' title='Windstream Holdings, Inc.'>WIN</a>) <font color='red'>fell 10.7%</font> yesterday after news of a noteholder claiming a default tied to how Windstream spun off its Communications Sales &amp; Leasing unit (now Uniti Group (<a href=\"http://seekingalpha.com/symbol/UNIT\" target=\"_blank\">UNIT</a> <font color='red'>-5.9%</font>)), but it <a href=\"http://www.barrons.com/articles/whats-up-with-windstream-1506530844\" target=\"_blank\">got some backup today</a> from one credit research firm that buys Windstream's take on the situation.</li>    <li>A creditor (surely Aurelius Capital Management) has said that asset transfers in the 2015 deal were a sale-leaseback transaction in violation of bond covenants.</li>    <li>Covenant Review doesn't agree, though it does admit \"litigation is inherently unpredictable.\"</li>    <li>Meanwhile research firm Reorg thinks Aurelius may have a point: \"To the extent that one is able to construe the contribution of the Contributed Assets, Spin-Off and Lease as a Sale and Leaseback transaction under the indentures, then the contribution may have violated the Sale and Leaseback Transactions covenant.\"</li>    <li>Shares of <a href='https://seekingalpha.com/symbol/WIN' title='Windstream Holdings, Inc.'>WIN</a> rebounded somewhat today, <font color='green'>up 5.1%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3298038\" data-linked=\"Windstream rebounds 5% as firms debate bond-default claim\" data-tweet=\"$WIN $WINMQ $UNIT - Windstream rebounds 5% as firms debate bond-default claim https://seekingalpha.com/news/3298038-windstream-rebounds-5-firms-debate-bond-default-claim?source=tweet\" data-url=\"https://seekingalpha.com/news/3298038-windstream-rebounds-5-firms-debate-bond-default-claim\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:32 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>21&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3298037\" data-ts=\"1506550932\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ABT\" target=\"_blank\">ABT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3298037-abbott-labsplus-3_5-after-fda-oks-blood-glucose-monitoring-device\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Abbott Labs +3.5% after FDA OKs blood glucose monitoring device</a></h4><ul>     <li>Abbott Laboratories (NYSE:<a href='https://seekingalpha.com/symbol/ABT' title='Abbott Laboratories'>ABT</a>) <font color='green'>+3.5%</font>&nbsp;AH on news that the FDA <a href=\"https://seekingalpha.com/pr/16953330-routine-finger-sticks-1-americans-diabetes-abbott-s-freestyle-libre-approved-u-s\" target=\"_blank\">approved</a> its FreeStyle Libre Flash glucose monitoring device as a replacement for blood glucose monitoring for adults with diabetes.</li>     <li>The approval means the ~30M people with diabetes in the U.S. can now track their blood sugar levels without the need to prick their fingers.</li>     <li>ABT's device uses a small sensor worn on the back of the upper arm to continuously measure and monitor glucose levels for up to 10 days, making it the longest lasting personal glucose sensor available in the U.S.</li>     <li>Glucose monitoring systems focused company Dexcom (NASDAQ:<a href='https://seekingalpha.com/symbol/DXCM' title='DexCom, Inc.'>DXCM</a>) <font color='red'>-15.8%</font> AH on ABT's news.</li></ul><div class=\"tiny-share-widget\" data-id=\"3298037\" data-linked=\"Abbott Labs +3.5% after FDA OKs blood glucose monitoring device\" data-tweet=\"$ABT $ABT $DXCM - Abbott Labs +3.5% after FDA OKs blood glucose monitoring device https://seekingalpha.com/news/3298037-abbott-labsplus-3_5-after-fda-oks-blood-glucose-monitoring-device?source=tweet\" data-url=\"https://seekingalpha.com/news/3298037-abbott-labsplus-3_5-after-fda-oks-blood-glucose-monitoring-device\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:22 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>35&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3298033\" data-ts=\"1506549603\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CBS\" target=\"_blank\">CBS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3298033-jpmorgan-analyst-bet-against-cbs-on-anthem-flap\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">JPMorgan analyst: Bet against CBS on anthem flap</a></h4><ul>   <li>JPMorgan analyst Shawn Quigg believes President Trump's war on the NFL over protesting players will have a real impact on media shares, and is <a href=\"https://www.bloomberg.com/news/articles/2017-09-27/jpmorgan-suggests-bet-against-cbs-amid-nfl-anthem-controversy\" target=\"_blank\">betting against CBS</a> (<a href=\"http://seekingalpha.com/symbol/CBS\" target=\"_blank\">CBS</a> <font color='green'>+0.4%</font>) in particular with a new weekend of games coming up.</li>    <li>Football ratings for the past weekend (when multiple teams' players coordinated protests during the playing of the National Anthem) were up Y/Y, though overall season-to-date ratings are down 11%.</li>    <li>But Quigg is recommending buying $57.50 puts on <a href='https://seekingalpha.com/symbol/CBS' title='CBS Corporation'>CBS</a>, expecting the price to fall after ratings come out for the coming weekend. CBS closed at $58.21 today.</li>    <li>&ldquo;NFL-related revenue is not trivial to CBS, and any decline in NFL viewership related to the National Anthem debate may negatively affect future results,&rdquo; Quigg writes. &ldquo;We view this weekend&rsquo;s viewership results as a cleaner proxy in determining whether the Anthem debate may be a larger issue for the NFL, and CBS, or not.&rdquo;</li>    <li>Quigg also pointed to a surge in jersey sales for Pittsburgh Steeler Alejandro Villanueva (who was the only one on his team to stand during their game) as backup for his sentiment.</li>    <li>Early numbers from Sunday games showed CBS contests <a href=\"https://seekingalpha.com/news/3297376-football-ratings-inconclusive-trumps-boycott-call\" target=\"_blank\">gaining 4% Y/Y</a>, while NBC (<a href=\"http://seekingalpha.com/symbol/CMCSA\" target=\"_blank\">CMCSA</a> <font color='green'>+1.9%</font>) saw its Sunday night ratings fall slightly.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3298033\" data-linked=\"JPMorgan analyst: Bet against CBS on anthem flap\" data-tweet=\"$CBS $VIAC $CMCSA - JPMorgan analyst: Bet against CBS on anthem flap https://seekingalpha.com/news/3298033-jpmorgan-analyst-bet-against-cbs-on-anthem-flap?source=tweet\" data-url=\"https://seekingalpha.com/news/3298033-jpmorgan-analyst-bet-against-cbs-on-anthem-flap\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:00 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>17&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3298031\" data-ts=\"1506548935\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AAAP\" target=\"_blank\">AAAP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3298031-bloomberg-novartis-considering-deal-for-advanced-accelerator\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Bloomberg: Novartis considering deal for Advanced Accelerator</a></h4><ul>     <li>Advanced Accelerator Applications (NASDAQ:<a href='https://seekingalpha.com/symbol/AAAP' title='Advanced Accelerator Applications'>AAAP</a>) <font color='green'>+11.6%</font>&nbsp;AH following a Bloomberg report that Novartis (NYSE:<a href='https://seekingalpha.com/symbol/NVS' title='Novartis AG'>NVS</a>) is <a href=\"https://www.bloomberg.com/news/articles/2017-09-27/novartis-is-said-to-consider-acquisition-of-advanced-accelerator\" target=\"_blank\">considering a deal for the company</a>.</li>     <li>NVS has approached AAAP about a deal and  held talks, according to the report, which says the company also could attract interest from other drugmakers,</li><li>The Swiss company makes radioactive drugs, used to diagnose and treat diseases such as cancer; its ADR have more than doubled YTD.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3298031\" data-linked=\"Bloomberg: Novartis considering deal for Advanced Accelerator\" data-tweet=\"$AAAP $AAAP $NVS - Bloomberg: Novartis considering deal for Advanced Accelerator https://seekingalpha.com/news/3298031-bloomberg-novartis-considering-deal-for-advanced-accelerator?source=tweet\" data-url=\"https://seekingalpha.com/news/3298031-bloomberg-novartis-considering-deal-for-advanced-accelerator\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:48 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3298029\" data-ts=\"1506548100\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3298029-after-hours-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">After Hours Gainers / Losers</a></h4><ul>     <li><b>Top gainers, as of 5.25 p.m.:</b> <a href='https://seekingalpha.com/symbol/AAAP' title='Advanced Accelerator Applications'>AAAP</a> <font color='green'>+15.7%</font>. <a href='https://seekingalpha.com/symbol/CHMA' title='Chiasma'>CHMA</a> <font color='green'>+8.2%</font>. <a href='https://seekingalpha.com/symbol/VNET' title='21Vianet Group'>VNET</a> <font color='green'>+3.6%</font>.</li><li><b>Top losers, as of 5.25p.m.:</b> <a href='https://seekingalpha.com/symbol/CMTL' title='Comtech Telecommunications Corp.'>CMTL</a> <font color='red'>-15.3%</font>. <a href='https://seekingalpha.com/symbol/DXCM' title='DexCom, Inc.'>DXCM</a> <font color='red'>-9.6%</font>. <a href='https://seekingalpha.com/symbol/PIR' title='Pier 1 Imports Inc.'>PIR</a> <font color='red'>-7.6%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3298029\" data-linked=\"After Hours Gainers / Losers\" data-tweet=\"$AAAP $CHMA $VNET - After Hours Gainers / Losers https://seekingalpha.com/news/3298029-after-hours-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3298029-after-hours-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:35 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>12&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3298025\" data-ts=\"1506546483\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SNE\" target=\"_blank\">SNE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3298025-disney-behind-scenes-content-headed-to-movie-pre-shows\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Disney behind-the-scenes content headed to movie pre-shows</a></h4><ul>   <li>Disney (<a href=\"http://seekingalpha.com/symbol/DIS\" target=\"_blank\">DIS</a> <font color='green'>+0.6%</font>) is partnering with movie-theater advertising firm National CineMedia (<a href=\"http://seekingalpha.com/symbol/NCMI\" target=\"_blank\">NCMI</a> <font color='green'>+3.1%</font>) on new pre-movie content that will have exclusive behind-the-scenes footage for a number of upcoming <i>Star Wars</i> and Marvel films.</li>    <li>National CineMedia launches <i>Noovie</i> on Friday, its replacement for <i>FirstLook</i>, a pre-show roll that has played out before features on thousands of national screens for more than a decade.</li>    <li>The deal starts with content tied to the Pixar film <i>Coco,</i> but will eventually offer exclusive content around <i>Star Wars: The Last Jedi</i> and the untitled Han Solo movie, as well as <i>Avengers: Infinity War</i> and <i>Black Panther,</i> and <i>The Incredibles 2</i> and others.</li>    <li><i>Noovie</i> also has a partnership with Sony Music's (NYSE:<a href='https://seekingalpha.com/symbol/SNE' title='Sony Corporation'>SNE</a>) Rumble Yard, which is sharing behind-the-scenes video of the Foo Fighters from the band's Acropolis show.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3298025\" data-linked=\"Disney behind-the-scenes content headed to movie pre-shows\" data-tweet=\"$SNE $SNE $DIS - Disney behind-the-scenes content headed to movie pre-shows https://seekingalpha.com/news/3298025-disney-behind-scenes-content-headed-to-movie-pre-shows?source=tweet\" data-url=\"https://seekingalpha.com/news/3298025-disney-behind-scenes-content-headed-to-movie-pre-shows\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:08 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3298022\" data-ts=\"1506545200\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CMTL\" target=\"_blank\">CMTL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3298022-comtech-telecomminus-10_4-q4-revenues-decline-and-miss\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Comtech Telecom -10.4% as Q4 revenues decline and miss</a></h4><ul>   <li>Comtech Telecommunications (NASDAQ:<a href='https://seekingalpha.com/symbol/CMTL' title='Comtech Telecommunications Corp.'>CMTL</a>) is <font color='red'>off 10.4%</font> after hours following <a href=\"https://seekingalpha.com/news/3297999-comtech-telecommunications-beats-0_02-misses-revenue\" target=\"_blank\">Q4 earnings</a> where revenues declined and missed, though income rose and topped expectations.</li>    <li>Operating income (GAAP basis) rose to $14.8M from $7.5M, and net income on that basis increased to $7.3M from $2.7M. Adjusted EBITDA came to $29.1M, above an expected $26.2M.</li>    <li>Book-to-bill ratio came to 0.90; as of July 31, backlog was $446.2M.</li>    <li>Cash and equivalents came to $41.8M after cash flow from operations of $23M.</li>    <li>It's set fiscal 2018 targets for revenue of $550M-$575M (vs. consensus for $567M), GAAP EPS of $0.41-$0.44 (above consensus for $0.40), and an effective income tax rate of 34.75%.</li>    <li><a href=\"http://www.comtechtel.com/eventdetail.cfm?EventID=185253\" target=\"_blank\">Conference call</a> to come tomorrow at 8:30 a.m. ET.</li>    <li><a href=\"https://seekingalpha.com/pr/16953228-comtech-telecommunications-corp-announces-results-fiscal-2017-fourth-quarter-full-year\" target=\"_blank\">Press Release</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3298022\" data-linked=\"Comtech Telecom -10.4% as Q4 revenues decline and miss\" data-tweet=\"$CMTL - Comtech Telecom -10.4% as Q4 revenues decline and miss https://seekingalpha.com/news/3298022-comtech-telecomminus-10_4-q4-revenues-decline-and-miss?source=tweet\" data-url=\"https://seekingalpha.com/news/3298022-comtech-telecomminus-10_4-q4-revenues-decline-and-miss\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:46 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3298015\" data-ts=\"1506544824\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/JBL\" target=\"_blank\">JBL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3298015-jabil-reports-q4-beats-positive-guidance-shares-down-1\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Jabil reports Q4 beats, positive guidance; shares down 1%</a></h4><ul><li>        Jabil (NYSE:<a href='https://seekingalpha.com/symbol/JBL' title='Jabil Inc.'>JBL</a>) shares are&nbsp;<font color='red'>down 1.08%</font>&nbsp;aftermarket following Q4 earnings beats and a guidance straddle.</li><li>               Q1 guidance: revenue, $5.25B to $5.75B (consensus: $5.38B); core operating income (non-GAAP), $198M to $258M; EPS, $0.65 to $0.91 (consensus: $0.83). &nbsp;&nbsp;</li><li>               Diversified Manufacturing revenue was up 32% on the year to about $2.85B. In Q1, Jabil expects the segment to have a 13% growth on the year to $2.7B.&nbsp;</li><li>                  Electronics Manufacturing revenue rose 3% in the quarter to about $2.15B. The Q1 outlook expects a 3% year-over-year growth to $2.8B.    </li><li>                  Financials: Non-GAAP core operating income was $191M, up 77% on the prior year&rsquo;s quarter. Operating expenses had $241.8M spent for SG&amp;A, up 16%, and $7.7M spent on R&amp;D. Jabil ended the quarter with $1.2B in cash and equivalents.   </li><li>               <a href=\"https://seekingalpha.com/pr/16953190-jabil-posts-fourth-quarter-and-fiscal-year-2017-results\" target=\"_blank\">Press release</a> / <a href=\"http://jabil.gcs-web.com/static-files/d8e90211-ae3a-4888-a576-bfd1248506a0\" target=\"_blank\">Earnings slides</a>&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</li><li>Previously: <a href=\"https://seekingalpha.com/news/3297988-jabil-beats-0_02-beats-revenue\" target=\"_blank\">Jabil beats by $0.02, beats on revenue</a> (Sept. 27)</li></ul><div class=\"tiny-share-widget\" data-id=\"3298015\" data-linked=\"Jabil reports Q4 beats, positive guidance; shares down 1%\" data-tweet=\"$JBL - Jabil reports Q4 beats, positive guidance; shares down 1% https://seekingalpha.com/news/3298015-jabil-reports-q4-beats-positive-guidance-shares-down-1?source=tweet\" data-url=\"https://seekingalpha.com/news/3298015-jabil-reports-q4-beats-positive-guidance-shares-down-1\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:40 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3298008\" data-ts=\"1506544223\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DGX\" target=\"_blank\">DGX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3298008-hurricanes-to-trim-1_5-off-quests-q3-sales-projection-and-0_10-off-eps-shares-down-1-after\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Hurricanes to trim 1.5% off Quest&#39;s Q3 sales projection and $0.10 off EPS; shares down 1% after hours</a></h4><ul><li>Citing the impact of recent hurricanes, Quest Diagnostics (NYSE:<a href='https://seekingalpha.com/symbol/DGX' title='Quest Diagnostics Incorporated'>DGX</a>) <a href=\"https://seekingalpha.com/pr/16953226-quest-diagnostics-provides-update-impact-third-quarter-financial-results-hurricanes\" target=\"_blank\">lowers</a> its Q3 guidance. Revenues will be 1.5% lower than expected and EPS will be trimmed $0.10. The negative impact is largely attributed to operations in Florida and Texas, which the company says are back to normal.</li><li>Management will provide more detailed data when it releases Q3 results on October 19.</li><li>Shares are down&nbsp;<font color='red'>1%</font>&nbsp;after hours on light volume.</li></ul><div class=\"tiny-share-widget\" data-id=\"3298008\" data-linked=\"Hurricanes to trim 1.5% off Quest&#39;s Q3 sales projection and $0.10 off EPS; shares down 1% after hours\" data-tweet=\"$DGX - Hurricanes to trim 1.5% off Quest&#39;s Q3 sales projection and $0.10 off EPS; shares down 1% after hours https://seekingalpha.com/news/3298008-hurricanes-to-trim-1_5-off-quests-q3-sales-projection-and-0_10-off-eps-shares-down-1-after?source=tweet\" data-url=\"https://seekingalpha.com/news/3298008-hurricanes-to-trim-1_5-off-quests-q3-sales-projection-and-0_10-off-eps-shares-down-1-after\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:30 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3298007\" data-ts=\"1506544058\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PIR\" target=\"_blank\">PIR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3298007-pier-1-imports-slumps-after-guidance-cut\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Pier 1 Imports slumps after guidance cut</a></h4><ul>     <li>Pier 1 Imports (NYSE:<a href='https://seekingalpha.com/symbol/PIR' title='Pier 1 Imports Inc.'>PIR</a>) falls after setting full-year profit guidance below expectations.</li>     <li>The company sees full-year EPS of $0.38 to $0.48 vs. $0.46 to $0.52 prior and $0.47 consensus. The impact on the retailer from Hurricanes Harvey and Irma are included in the updated numbers.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3297997-pier-1-imports-beats-0_01-beats-revenue\" target=\"_blank\">Pier 1 Imports beats by $0.01, beats on revenue</a> (Sept. 27)</li><li>Shares of Pier 1 are down&nbsp;<font color='red'>8.67%&nbsp;</font>in AH trading.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3298007\" data-linked=\"Pier 1 Imports slumps after guidance cut\" data-tweet=\"$PIR - Pier 1 Imports slumps after guidance cut https://seekingalpha.com/news/3298007-pier-1-imports-slumps-after-guidance-cut?source=tweet\" data-url=\"https://seekingalpha.com/news/3298007-pier-1-imports-slumps-after-guidance-cut\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:27 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3298005\" data-ts=\"1506543693\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PRGS\" target=\"_blank\">PRGS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3298005-progress-software-beats-0_01-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Progress Software beats by $0.01, beats on revenue</a></h4><ul><li>Progress Software (NASDAQ:<a href='https://seekingalpha.com/symbol/PRGS' title='Progress Software Corporation'>PRGS</a>): Q3 EPS of $0.48 <font color='green'>beats by $0.01</font>.</li><li>Revenue of $97.62M (-4.7% Y/Y) <font color='green'>beats by $0.52M</font>.</li><li>Shares <font color='green'>+2.25%</font>.</li><li><a href='https://seekingalpha.com/pr/16953219-progress-reports-2017-fiscal-third-quarter-results-increases-annual-guidance'>Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3298005\" data-linked=\"Progress Software beats by $0.01, beats on revenue\" data-tweet=\"$PRGS - Progress Software beats by $0.01, beats on revenue https://seekingalpha.com/news/3298005-progress-software-beats-0_01-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3298005-progress-software-beats-0_01-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:21 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3298003\" data-ts=\"1506543579\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ENZ\" target=\"_blank\">ENZ</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3298003-enzo-biochem-fq4-top-line-up-6-non-gaap-earnings-up-105-shares-up-6-after-hours\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Enzo Biochem FQ4 top line up 6%; non-GAAP earnings up 105%; shares up 6% after hours</a></h4><ul><li>Enzo Biochem (NYSE:<a href='https://seekingalpha.com/symbol/ENZ' title='Enzo Biochem, Inc.'>ENZ</a>) <a href=\"https://seekingalpha.com/pr/16953194-enzo-biochem-reports-increase-revenues-profitable-fourth-quarter\" target=\"_blank\">fiscal Q4 results</a> ($M): Revenues: 28.2 (+6.0%); Clinical Lab Services: 20.4 (+12.7%); Non-GAAP Net Income: 0.1 (+104.8%).</li><li>Comparative GAAP earnings impacted by legal settlements and licensing payments in the prior period.</li><li>Shares are up&nbsp;<font color='green'>6%</font>&nbsp;after hours on light volume.</li></ul><div class=\"tiny-share-widget\" data-id=\"3298003\" data-linked=\"Enzo Biochem FQ4 top line up 6%; non-GAAP earnings up 105%; shares up 6% after hours\" data-tweet=\"$ENZ - Enzo Biochem FQ4 top line up 6%; non-GAAP earnings up 105%; shares up 6% after hours https://seekingalpha.com/news/3298003-enzo-biochem-fq4-top-line-up-6-non-gaap-earnings-up-105-shares-up-6-after-hours?source=tweet\" data-url=\"https://seekingalpha.com/news/3298003-enzo-biochem-fq4-top-line-up-6-non-gaap-earnings-up-105-shares-up-6-after-hours\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:19 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3297998\" data-ts=\"1506543458\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/THO\" target=\"_blank\">THO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3297998-thor-beats-0_32-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Thor beats by $0.32, beats on revenue</a></h4><ul><li>Thor (NYSE:<a href='https://seekingalpha.com/symbol/THO' title='Thor Industries, Inc.'>THO</a>): Q4 EPS of $2.26 <font color='green'>beats by $0.32</font>.</li><li>Revenue of $1.93B (+49.6% Y/Y) <font color='green'>beats by $100M</font>.</li><li>Shares <font color='green'>+2.75%</font>.</li><li><a href='https://seekingalpha.com/pr/16953227-thor-announces-record-results-fourth-quarter-full-year-fiscal-2017'>Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3297998\" data-linked=\"Thor beats by $0.32, beats on revenue\" data-tweet=\"$THO - Thor beats by $0.32, beats on revenue https://seekingalpha.com/news/3297998-thor-beats-0_32-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3297998-thor-beats-0_32-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:17 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>10&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3297994\" data-ts=\"1506543179\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AMBA\" target=\"_blank\">AMBA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3297994-ambarella-up-6_5-after-morgan-stanley-bull-case\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ambarella up 6.5% after Morgan Stanley bull case</a></h4><ul><li>        Ambarella (NASDAQ:<a href='https://seekingalpha.com/symbol/AMBA' title='Ambarella'>AMBA</a>) shares close&nbsp;<font color='green'>up 6.51%</font>&nbsp;to $48.57 today after Morgan Stanley gave the company a $115 <a href=\"https://www.benzinga.com/analyst-ratings/analyst-color/17/09/10106939/morgan-stanley-calls-for-150-upside-in-ambarella\" target=\"_blank\">bull case</a> on technology driving the AI space.</li><li>               Analysts Joseph Moore and Craig Hettenbach cite Ambarella&rsquo;s optimism about its advanced dedicated computer vision chips, which could make the company a market leader if the products live up to expectations.&nbsp;</li><li>               Most CV functions happen with programmable chips so Ambarella would join only Intel&rsquo;s Mobileye and Movidius in the dedicated CV chip space. &nbsp;&nbsp;</li><li>               The analysts note that it could be a long while before Ambarella starts bringing in CV revenue but they also see near-term potential in developing supplier relationships in the autonomous vehicle space, though that doesn&rsquo;t support the bull case pricing.&nbsp;</li><li>                  Morgan Stanley has an Overweight rating and $60 price target on Ambarella.&nbsp; </li><li>Previously: <a href=\"https://seekingalpha.com/news/3296933-stifel-analyst-thinks-ambarella-appears-new-nest-doorbell-update\" target=\"_blank\">Stifel analyst thinks Ambarella appears in new Nest doorbell (update)</a> (Sept. 21)</li></ul><div class=\"tiny-share-widget\" data-id=\"3297994\" data-linked=\"Ambarella up 6.5% after Morgan Stanley bull case\" data-tweet=\"$AMBA - Ambarella up 6.5% after Morgan Stanley bull case https://seekingalpha.com/news/3297994-ambarella-up-6_5-after-morgan-stanley-bull-case?source=tweet\" data-url=\"https://seekingalpha.com/news/3297994-ambarella-up-6_5-after-morgan-stanley-bull-case\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:12 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>10&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3297993\" data-ts=\"1506543097\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WMC\" target=\"_blank\">WMC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3297993-western-asset-mortgage-convertible-offering-shares-down-1_4-ah\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Western Asset Mortgage with convertible offering; shares down 1.4% AH</a></h4><ul><li>The company is selling $100M of five year convertible senior notes. Underwriters will be granted an option to buy up to an additional $15M of the paper.</li><li><a href='https://seekingalpha.com/symbol/WMC' title='Western Asset Mortgage Capital Corporation'>WMC</a>&nbsp;<font color='red'>-1.4%</font>&nbsp;after hours</li><li>Source: <a href=\"https://seekingalpha.com/pr/16953203-western-asset-mortgage-capital-corporation-announces-proposed-public-offering-convertible\" target=\"_blank\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3297993\" data-linked=\"Western Asset Mortgage with convertible offering; shares down 1.4% AH\" data-tweet=\"$WMC - Western Asset Mortgage with convertible offering; shares down 1.4% AH https://seekingalpha.com/news/3297993-western-asset-mortgage-convertible-offering-shares-down-1_4-ah?source=tweet\" data-url=\"https://seekingalpha.com/news/3297993-western-asset-mortgage-convertible-offering-shares-down-1_4-ah\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:11 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3297992\" data-ts=\"1506543018\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SINO\" target=\"_blank\">SINO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3297992-sino-global-shipping-america-reports-q4-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sino-Global Shipping America reports Q4 results</a></h4><ul><li>Sino-Global Shipping America (NASDAQ:<a href='https://seekingalpha.com/symbol/SINO' title='Sino-Global Shipping America, Ltd.'>SINO</a>): Q4 EPS of $0.07</li><li>Revenue of $4.62M (+151.1% Y/Y)</li><li>Shares <font color='green'>+11%</font>.</li><li><a href='https://seekingalpha.com/pr/16953195-sino-global-announces-2017-year-end-financial-results'>Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3297992\" data-linked=\"Sino-Global Shipping America reports Q4 results\" data-tweet=\"$SINO - Sino-Global Shipping America reports Q4 results https://seekingalpha.com/news/3297992-sino-global-shipping-america-reports-q4-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3297992-sino-global-shipping-america-reports-q4-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:10 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3297987\" data-ts=\"1506542372\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ECA\" target=\"_blank\">ECA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3297987-encana-delivers-new-montney-plant-maintains-2017-production-guidance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Encana delivers new Montney plant; maintains 2017 production guidance</a></h4><ul>     <li>Encana (<a href='https://seekingalpha.com/symbol/ECA' title='Encana Corporation'>ECA</a> <font color='green'>+2%</font>) is higher after announcing the <a href=\"https://seekingalpha.com/pr/16952130-encana-delivers-new-montney-plant-ahead-schedule-company-continues-outperform-five-year-plan\" target=\"_blank\">successful start-up</a> of its Tower processing plant in the Montney gas field, ahead of schedule and under budget.</li>     <li>The plant is the first of three Veresen Midstream facilities that ECA says will more than double its Montney liquids production in Q4 2017 from the prior-year quarter; ECA says the two other new plants also are ahead of schedule and under budget, with start-up expected before year-end.</li><li>ECA also says it will meet its full-year production guidance despite  losing 3,500 boe/day during Q3 from U.S. operations it suspended because of Hurricane Harvey.</li></ul><div class=\"tiny-share-widget\" data-id=\"3297987\" data-linked=\"Encana delivers new Montney plant; maintains 2017 production guidance\" data-tweet=\"$ECA - Encana delivers new Montney plant; maintains 2017 production guidance https://seekingalpha.com/news/3297987-encana-delivers-new-montney-plant-maintains-2017-production-guidance?source=tweet\" data-url=\"https://seekingalpha.com/news/3297987-encana-delivers-new-montney-plant-maintains-2017-production-guidance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:59 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3297984\" data-ts=\"1506542347\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AGN\" target=\"_blank\">AGN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3297984-allergan-under-modest-pressure-on-report-senators-may-investigate-restasis-patent-deal-regis\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Allergan under modest pressure on report that Senators may investigate Restasis patent deal with Regis Mohawk Tribe; shares down 1%</a></h4><ul><li>Allergan (<a href='https://seekingalpha.com/symbol/AGN' title='Allergan plc'>AGN</a> <font color='red'>-0.7%</font>) eases on light volume on reports that U.S. Senators may look into its legal maneuver to protect its patents covering dry eye med RESTASIS (Cyclosporine Ophthalmic Emulsion).</li><li>Source: Bloomberg</li><li>Previously: <a href=\"https://seekingalpha.com/news/3294452-allergan-uses-legal-maneuver-sovereign-tribal-government-protect-restasis-patents\" target=\"_blank\">Allergan uses legal maneuver with sovereign tribal government to protect Restasis patents</a> (Sept. 8)</li></ul><div class=\"tiny-share-widget\" data-id=\"3297984\" data-linked=\"Allergan under modest pressure on report that Senators may investigate Restasis patent deal with Regis Mohawk Tribe; shares down 1%\" data-tweet=\"$AGN - Allergan under modest pressure on report that Senators may investigate Restasis patent deal with Regis Mohawk Tribe; shares down 1% https://seekingalpha.com/news/3297984-allergan-under-modest-pressure-on-report-senators-may-investigate-restasis-patent-deal-regis?source=tweet\" data-url=\"https://seekingalpha.com/news/3297984-allergan-under-modest-pressure-on-report-senators-may-investigate-restasis-patent-deal-regis\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:59 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>19&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3297983\" data-ts=\"1506542135\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/OUT\" target=\"_blank\">OUT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3297983-outfront-mediaplus-3_8-confirms-new-deal-new-york-mta\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Outfront Media +3.8% as it confirms new deal with New York MTA</a></h4><ul>   <li>Outfront Media (NYSE:<a href='https://seekingalpha.com/symbol/OUT' title='Outfront Media, Inc.'>OUT</a>) is <font color='green'>up 3.8%</font> as it confirms it's <a href=\"https://seekingalpha.com/pr/16953151-outfront-media-awarded-long-term-contract-new-york-metropolitan-transportation-authority\" target=\"_blank\">renewed a long-term ad deal</a> from New York's MTA, the largest public transit authority in the country.</li>    <li>The deal from the Metropolitan Transportation Authority gives Outfront the ad and communications concessions for subway, commuter rail and buses along with billboards.</li>    <li>Outfront will deploy more than 50,000 digital ad displays systemwide, installed on a rolling basis starting next year. It will also continue maintaining more than 500 billboard locations for the MTA.</li>    <li>The company's <a href=\"https://event.on24.com/wcc/r/1517275/7118BC132FC948E8B05910567BC34C40\" target=\"_blank\">holding a conference call</a> to discuss the deal tomorrow at 8:30 a.m. ET.</li>    <li>Shares have <font color='green'>risen 13.8%</font> this week.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3297983\" data-linked=\"Outfront Media +3.8% as it confirms new deal with New York MTA\" data-tweet=\"$OUT - Outfront Media +3.8% as it confirms new deal with New York MTA https://seekingalpha.com/news/3297983-outfront-mediaplus-3_8-confirms-new-deal-new-york-mta?source=tweet\" data-url=\"https://seekingalpha.com/news/3297983-outfront-mediaplus-3_8-confirms-new-deal-new-york-mta\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:55 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3297980\" data-ts=\"1506541599\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VERI\" target=\"_blank\">VERI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3297980-veritone-slides-citron-says-stock-should-be-70-lower\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Veritone slides as Citron says stock should be 70% lower</a></h4><ul>   <li>Veritone (NASDAQ:<a href='https://seekingalpha.com/symbol/VERI' title='Veritone'>VERI</a>) is in the doldrums (<font color='red'>down 27.5%</font>) after a late-morning <a href=\"https://twitter.com/CitronResearch/status/913054305619283968\" target=\"_blank\">tweet</a> from short seller Citron Research picked a fair-value price 70% below yesterday's close.</li>    <li>The company \"is not artificial intelligence, more like natural stupidity,\" Citron says in the tweet. \"Stock should trade right back to $20.\"</li>    <li>Shares had closed at $65.91 yesterday; they're down more than $18/share to $47.80 shortly before the close.</li>    <li>The company's stock had <a href=\"https://seekingalpha.com/news/3296913-veritone-plus-17-percent-ai-platform-awarded-best-ibc\" target=\"_blank\">jumped last week</a> after its artificial-intelligence platform won best of show at IBC.</li>    <li>Citron, meanwhile, has of late focused its bearish power on Ubiquiti Networks, which it's <a href=\"https://seekingalpha.com/news/3296039-ubiquiti-networks-fraud-claims-citron-research\" target=\"_blank\">calling a \"total fraud.\"</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3297980\" data-linked=\"Veritone slides as Citron says stock should be 70% lower\" data-tweet=\"$VERI - Veritone slides as Citron says stock should be 70% lower https://seekingalpha.com/news/3297980-veritone-slides-citron-says-stock-should-be-70-lower?source=tweet\" data-url=\"https://seekingalpha.com/news/3297980-veritone-slides-citron-says-stock-should-be-70-lower\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:46 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>37&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3297976\" data-ts=\"1506540769\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GOOG\" target=\"_blank\">GOOG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3297976-house-asking-social-media-firms-russian-fracking-ad-buys\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">House asking social-media firms about Russian fracking ad buys</a></h4><ul>   <li>Alongside news that social media companies will be <a href=\"https://seekingalpha.com/news/3296972-facebook-release-russian-bought-ads-investigators\" target=\"_blank\">headed to Senate testimony</a> over Russian attempts to influence the U.S. presidential election, a House committee is asking them for information with regard to efforts to <a href=\"https://finance.yahoo.com/news/u-lawmakers-ask-facebook-twitter-155911117.html\" target=\"_blank\">influence opinion on fossil fuels</a>.</li>    <li>The House Science and Technology Committee, chaired by Republican Lamar Smith, is asking Facebook (<a href=\"http://seekingalpha.com/symbol/FB\" target=\"_blank\">FB</a> <font color='green'>+2.3%</font>), Twitter (<a href=\"http://seekingalpha.com/symbol/TWTR\" target=\"_blank\">TWTR</a> <font color='green'>+2.3%</font>) and Alphabet (<a href='https://seekingalpha.com/symbol/GOOG' title='Alphabet, Inc. Cl C'>GOOG</a> <font color='green'>+2.6%</font>, <a href='https://seekingalpha.com/symbol/GOOGL' title='Alphabet, Inc. Cl A'>GOOGL</a> <font color='green'>+2.8%</font>) to hand over information about Russian entities that might have bought advertisements critical of hydraulic fracturing (\"fracking\") or advocating \"so-called green initiatives.\"</li>    <li>\"The committee is concerned that divisive social media and political messages conveyed through social media have negatively affected certain energy sectors, which can depress research and development in the fossil fuel sector and expanding potential for natural gas,\" Smith writes in a letter to the companies' CEOs.</li>    <li>The move is the latest in what may become a groundswell of scrutiny of the firms from both political parties, and potentially heavy new regulation.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3297976\" data-linked=\"House asking social-media firms about Russian fracking ad buys\" data-tweet=\"$GOOG $GOOG $GOOGL - House asking social-media firms about Russian fracking ad buys https://seekingalpha.com/news/3297976-house-asking-social-media-firms-russian-fracking-ad-buys?source=tweet\" data-url=\"https://seekingalpha.com/news/3297976-house-asking-social-media-firms-russian-fracking-ad-buys\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:32 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>11&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3297975\" data-ts=\"1506540431\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AMAT\" target=\"_blank\">AMAT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3297975-applied-materials-provides-three-year-guidance-shares-up-7_5\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Applied Materials provides three-year guidance; shares up 7.5%</a></h4><ul><li>        Applied Materials (NASDAQ:<a href='https://seekingalpha.com/symbol/AMAT' title='Applied Materials, Inc.'>AMAT</a>) shares are&nbsp;<font color='green'>up 7.51%</font>&nbsp;after the company&nbsp;<a href=\"https://seekingalpha.com/pr/16953148-applied-materials-enabling-bigger-waves-profitable-growth\" target=\"_blank\">reveals</a> its three-year outlook during today&rsquo;s 2017 Analyst Day.</li><li>               The company targets non-GAAP adjusted EPS of $5.08 for FY20 based on a $45B wafer fab equipment market and an increased market share that would also drive up margins, R&amp;D investments, and operating profit.&nbsp;</li><li>               AMAT expects wafer fab equipment spending to total $90B for this year and 2018 combined. The spending comes from a need to up production capacity for NAND, DRAM, and silicon content for smartphones.&nbsp;</li><li>                  In the Services segment, AMAT expects to deliver a 15% CAGR for the next three years, reaching $4.5B in 2020.    </li><li>               The Display segment should deliver a 23% CAGR over the same period.&nbsp;</li><li>                  AMAT also announces a new $3B share repurchase program that adds to the $995M still remaining, as of Q3&rsquo;s end, from the prior approved program. &nbsp;&nbsp;<br /><br />&nbsp;   &nbsp;</li></ul><div class=\"tiny-share-widget\" data-id=\"3297975\" data-linked=\"Applied Materials provides three-year guidance; shares up 7.5%\" data-tweet=\"$AMAT - Applied Materials provides three-year guidance; shares up 7.5% https://seekingalpha.com/news/3297975-applied-materials-provides-three-year-guidance-shares-up-7_5?source=tweet\" data-url=\"https://seekingalpha.com/news/3297975-applied-materials-provides-three-year-guidance-shares-up-7_5\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:27 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3297971\" data-ts=\"1506539869\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/UNFI\" target=\"_blank\">UNFI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3297971-sellers-win-day-on-united-natural-foods\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sellers win the day on United Natural Foods</a></h4><ul>     <li>United Natural Foods (<a href='https://seekingalpha.com/symbol/UNFI' title='United Natural Foods, Inc.'>UNFI</a> <font color='red'>-3.9%</font>) falls after a minor round of insider sales was reported by the company.</li>     <li>The sellers were&nbsp;COO Sean Griffin (8.1K shares), compliance chief Joseph Traficanti (5.8K shares) and director James Heffernan (2.6K shares).</li><li>Sentiment may also be leaning to the negative side from yesterday's downgrade by Barclays on UNFI to Underweight.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3297971\" data-linked=\"Sellers win the day on United Natural Foods\" data-tweet=\"$UNFI - Sellers win the day on United Natural Foods https://seekingalpha.com/news/3297971-sellers-win-day-on-united-natural-foods?source=tweet\" data-url=\"https://seekingalpha.com/news/3297971-sellers-win-day-on-united-natural-foods\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:17 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3297965\" data-ts=\"1506538793\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3297965-small-caps-continue-major-surge-up-another-2-today\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Small caps continue major surge - up another 2% today</a></h4><ul><li>The Russell 2000 (NYSEARCA:<a href='https://seekingalpha.com/symbol/IWM' title='iShares Russell 2000 ETF'>IWM</a>) is outperforming by a mile today,&nbsp;<font color='green'>up 2%</font>&nbsp;vs. the S&amp;P 500's&nbsp;<font color='green'>0.5%</font>&nbsp;and the Nasdaq's&nbsp;<font color='green'>1.25% advance</font>.</li><li>It's a new intraday record for the Russell, and also puts the small-cap gauge ahead a&nbsp;<font color='green'>full 10%</font>&nbsp;since bottoming out for the summer one month ago.</li><li>ETFs: <a href='https://seekingalpha.com/symbol/VB' title='Vanguard Small Cap ETF'>VB</a>, <a href='https://seekingalpha.com/symbol/VBR' title='Vanguard Small-Cap Value ETF'>VBR</a>, <a href='https://seekingalpha.com/symbol/VBK' title='Vanguard Small Cap Growth ETF'>VBK</a>, <a href='https://seekingalpha.com/symbol/SCHA' title='Schwab U.S. Small-Cap ETF'>SCHA</a>, <a href='https://seekingalpha.com/symbol/RVT' title='Royce Value Trust'>RVT</a>, <a href='https://seekingalpha.com/symbol/EES' title='WisdomTree SmallCap Earnings ETF'>EES</a>, <a href='https://seekingalpha.com/symbol/FFTY' title='Innovator IBD 50 Fund'>FFTY</a>, <a href='https://seekingalpha.com/symbol/JKL' title='iShares Morningstar Small-Cap Value ETF'>JKL</a>, <a href='https://seekingalpha.com/symbol/RCG' title='RENN Global Entrepreneurs Fund'>RCG</a>, <a href='https://seekingalpha.com/symbol/TILT' title='FlexShares Morningstar U.S. Market Factor Tilt Index ETF'>TILT</a>, <a href='https://seekingalpha.com/symbol/FYX' title='First Trust Small Cap Core AlphaDEX ETF'>FYX</a>, <a href='https://seekingalpha.com/symbol/JKJ' title='iShares Morningstar Small-Cap ETF'>JKJ</a>, <a href='https://seekingalpha.com/symbol/JKK' title='iShares Morningstar Small-Cap Growth ETF'>JKK</a>, <a href='https://seekingalpha.com/symbol/VLU' title='SPDR S&P 1500 Value Title ETF'>VLU</a>, <a href='https://seekingalpha.com/symbol/FYT' title='First Trust Small Cap Value AlphaDEX ETF'>FYT</a>, <a href='https://seekingalpha.com/symbol/SMLF' title='iShares Edge MSCI Multifactor USA Small-Cap ETF'>SMLF</a>, <a href='https://seekingalpha.com/symbol/FYC' title='First Trust Small Cap Growth AlphaDEX ETF'>FYC</a>, <a href='https://seekingalpha.com/symbol/JSML' title='Janus Small Cap Growth Alpha ETF'>JSML</a>, <a href='https://seekingalpha.com/symbol/FLQS' title='Franklin LibertyQ U.S. Small Cap Equity ETF'>FLQS</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3297965\" data-linked=\"Small caps continue major surge - up another 2% today\" data-tweet=\"$IWM $VB $VBR - Small caps continue major surge - up another 2% today https://seekingalpha.com/news/3297965-small-caps-continue-major-surge-up-another-2-today?source=tweet\" data-url=\"https://seekingalpha.com/news/3297965-small-caps-continue-major-surge-up-another-2-today\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:59 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3297967\" data-ts=\"1506538754\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SCG\" target=\"_blank\">SCG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3297967-scana-santee-cooper-to-sell-claims-from-toshiba-for-failed-nuclear-project\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">SCANA, Santee Cooper to sell claims from Toshiba for failed nuclear project</a></h4><ul>     <li>SCANA (<a href='https://seekingalpha.com/symbol/SCG' title='SCANA Corporation'>SCG</a> <font color='red'>-7.1%</font>) says it has <a href=\"http://www.prnewswire.com/news-releases/south-carolina-electric--gas-company-monetizes-guaranty-settlement-payments-from-toshiba-300526979.html\" target=\"_blank\">sold the rights</a> to its portion of a $2.17B settlement with Toshiba to Citibank; Santee Cooper, SCH's partner in the abandoned V.C. Summer nuclear reactor project is making a similar move.</li>     <li>Under the agreement, Citi will pay 91.5% of the settlement claim, then SCG will receive $1.19B for its 55% share and Santee Cooper will get $831M for its 45% share.</li>     <li>SCG says the move avoids the credit risk associated with receiving payments from Toshiba spread out over five years period and ensures the funds are available to mitigate costs of the abandoned project.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3297967\" data-linked=\"SCANA, Santee Cooper to sell claims from Toshiba for failed nuclear project\" data-tweet=\"$SCG - SCANA, Santee Cooper to sell claims from Toshiba for failed nuclear project https://seekingalpha.com/news/3297967-scana-santee-cooper-to-sell-claims-from-toshiba-for-failed-nuclear-project?source=tweet\" data-url=\"https://seekingalpha.com/news/3297967-scana-santee-cooper-to-sell-claims-from-toshiba-for-failed-nuclear-project\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:59 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3297964\" data-ts=\"1506538508\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3297964-technology-top-gainers-losers-of-2-55-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Technology - Top Gainers / Losers as of 2:55 pm</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/MTSL' title='MER Telemanagement Solutions Ltd.'>MTSL</a> <font color='green'>+27%</font>. <a href='https://seekingalpha.com/symbol/ICAD' title='iCAD, Inc.'>ICAD</a> <font color='green'>+16%</font>. <a href='https://seekingalpha.com/symbol/MARK' title='Remark Holdings, Inc.'>MARK</a> <font color='green'>+15%</font>. <a href='https://seekingalpha.com/symbol/SITO' title='SITO Mobile, Ltd.'>SITO</a> <font color='green'>+12%</font>. <a href='https://seekingalpha.com/symbol/GRVY' title='GRAVITY Co., Ltd. - American depositary shares, each representing one'>GRVY</a> <font color='green'>+12%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/VERI' title='Veritone'>VERI</a> <font color='red'>-29%</font>. <a href='https://seekingalpha.com/symbol/VNET' title='21Vianet Group'>VNET</a> <font color='red'>-17%</font>. <a href='https://seekingalpha.com/symbol/IZEA' title='IZEA Worldwide, Inc.'>IZEA</a> <font color='red'>-9%</font>. <a href='https://seekingalpha.com/symbol/HMNY' title='Helios and Matheson Analytics, Inc.'>HMNY</a> <font color='red'>-8%</font>. <a href='https://seekingalpha.com/symbol/ANY' title='Sphere 3D Corp.'>ANY</a> <font color='red'>-8%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3297964\" data-linked=\"Technology - Top Gainers / Losers as of 2:55 pm\" data-tweet=\"$MTSL $ICAD $MARK - Technology - Top Gainers / Losers as of 2:55 pm https://seekingalpha.com/news/3297964-technology-top-gainers-losers-of-2-55-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3297964-technology-top-gainers-losers-of-2-55-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:55 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3297960\" data-ts=\"1506537102\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BW\" target=\"_blank\">BW</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3297960-babcock-wilcox-report-structural-steel-issue-renewable-energy-project\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Babcock &amp; Wilcox report &quot;structural steel issue&quot; at renewable energy project</a></h4><ul>     <li>Babcock &amp;&nbsp;Wilcox (<a href='https://seekingalpha.com/symbol/BW' title='Babcock & Wilcox Enterprises, Inc.'>BW</a> <font color='red'>-9.7%</font>) plunges as much as 29% after saying a subcontractor error on a U.K. renewable energy project could <a href=\"http://www.babcock.com/en/news/bw-provides-update-on-u-k-renewable-projects\" target=\"_blank\">raise project costs by $10M-$15M</a>.</li>     <li>BW says it has stopped work on the project while it studies ways to correct the structural steel mistake, and has halted two other U.K. projects with similar engineering designs, although it does not expect the redesign of those projects will be as expensive as fixing the error at the first project.</li>     <li>BW also says it is seeking to be reimbursed by a third party for some or possibly all extra costs on the three projects.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3297960\" data-linked=\"Babcock &amp; Wilcox report &quot;structural steel issue&quot; at renewable energy project\" data-tweet=\"$BW - Babcock &amp; Wilcox report &quot;structural steel issue&quot; at renewable energy project https://seekingalpha.com/news/3297960-babcock-wilcox-report-structural-steel-issue-renewable-energy-project?source=tweet\" data-url=\"https://seekingalpha.com/news/3297960-babcock-wilcox-report-structural-steel-issue-renewable-energy-project\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:31 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3297958\" data-ts=\"1506535786\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CPRI\" target=\"_blank\">CPRI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3297958-michael-kors-tracks-higher-on-canaccord-confidence\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Michael Kors tracks higher on Canaccord confidence</a></h4><ul>     <li>Shares of Michael Kors (KORS <font color='green'>+2.7%</font>) are higher after a shot of confidence from Canaccord Genuity.</li>     <li>\"We believe the turn KORS management is orchestrating will result in a multi-step P&amp;L march upward that will manifest through both comps and gross margins over the next few years, such that core ex-CHOO EBIT margins could approach 19% from 16% this year,\" writes analyst Camilo Lyon.</li><li>Canaccord upgrades MK to Buy from Hold and sets a price target of $58. The 52-week high on Kors is $52.67.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3297958\" data-linked=\"Michael Kors tracks higher on Canaccord confidence\" data-tweet=\"$CPRI - Michael Kors tracks higher on Canaccord confidence https://seekingalpha.com/news/3297958-michael-kors-tracks-higher-on-canaccord-confidence?source=tweet\" data-url=\"https://seekingalpha.com/news/3297958-michael-kors-tracks-higher-on-canaccord-confidence\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:09 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3297956\" data-ts=\"1506535293\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3297956-energy-materials-top-gainers-losers-of-2-00-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Energy/Materials - Top Gainers / Losers as of 2:00 pm</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/LXU' title='LSB Industries, Inc.'>LXU</a> <font color='green'>+8%</font>. <a href='https://seekingalpha.com/symbol/REXX' title='Rex Energy Corporation'>REXX</a> <font color='green'>+8%</font>. <a href='https://seekingalpha.com/symbol/AVD' title='American Vanguard Corporation'>AVD</a> <font color='green'>+7%</font>. <a href='https://seekingalpha.com/symbol/JONE' title='Jones Energy, Inc.'>OTC:JONE</a> <font color='green'>+6%</font>. <a href='https://seekingalpha.com/symbol/MTRN' title='Materion Corporation'>MTRN</a> <font color='green'>+5%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/TANH' title='Tantech Holdings'>TANH</a> <font color='red'>-31%</font>. <a href='https://seekingalpha.com/symbol/TAHO' title='Tahoe Resources Inc.'>TAHO</a> <font color='red'>-12%</font>. <a href='https://seekingalpha.com/symbol/NOG' title='Northern Oil & Gas, Inc'>NOG</a> <font color='red'>-9%</font>. <a href='https://seekingalpha.com/symbol/WLKP' title='Westlake Chemical Partners LP'>WLKP</a> <font color='red'>-8%</font>. <a href='https://seekingalpha.com/symbol/SND' title='Smart Sand'>SND</a> <font color='red'>-8%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3297956\" data-linked=\"Energy/Materials - Top Gainers / Losers as of 2:00 pm\" data-tweet=\"$LXU $REXX $AVD - Energy/Materials - Top Gainers / Losers as of 2:00 pm https://seekingalpha.com/news/3297956-energy-materials-top-gainers-losers-of-2-00-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3297956-energy-materials-top-gainers-losers-of-2-00-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:01 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3297952\" data-ts=\"1506534398\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CHEK\" target=\"_blank\">CHEK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3297952-check-cap-files-for-ce-mark-certification-for-c-scan-shares-ahead-7\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Check-Cap files for CE Mark certification for C-Scan; shares ahead 7%</a></h4><ul><li>Ultra-thinly traded nano cap Check-Cap (<a href='https://seekingalpha.com/symbol/CHEK' title='Check-Cap Ltd.'>CHEK</a> <font color='green'>+7.3%</font>) has <a href=\"https://seekingalpha.com/pr/16952188-check-cap-announces-filing-ce-mark-registration-c-scan\" target=\"_blank\">filed </a>for CE Mark registration for ingestible colorectal cancer screening device <a href=\"http://www.check-cap.com/\" target=\"_blank\">C-Scan</a>.</li><li>The data supporting the submission was generated in a study designed to assess C-Scan's ability to detect polyps. The results showed 44% sensitivity (correctly identifying true positives) and 89% specificity (correctly identifying true negatives) in 45 subjects.</li><li>Sensitivity strongly correlated with the percentage of the colon scanned, 100% when at least 70% of the colon was scanned and 78% when at least half the colon was scanned. Specificity was consistent throughout.</li><li>In a note, Maxim Group says it is \"worried\" that the 44% sensitivity is too low, but it can improve with better software. It expects the CE Mark to be issued.</li><li>Source: Bloomberg</li></ul><div class=\"tiny-share-widget\" data-id=\"3297952\" data-linked=\"Check-Cap files for CE Mark certification for C-Scan; shares ahead 7%\" data-tweet=\"$CHEK - Check-Cap files for CE Mark certification for C-Scan; shares ahead 7% https://seekingalpha.com/news/3297952-check-cap-files-for-ce-mark-certification-for-c-scan-shares-ahead-7?source=tweet\" data-url=\"https://seekingalpha.com/news/3297952-check-cap-files-for-ce-mark-certification-for-c-scan-shares-ahead-7\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:46 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3297949\" data-ts=\"1506532303\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CI\" target=\"_blank\">CI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3297949-health-insurers-under-pressure-on-looming-trump-order-allowing-interstate-purchase-of\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Health insurers under pressure on looming Trump order allowing interstate purchase of insurance</a></h4><ul><li>Health insurance firms are under the gun after President Trump <a href=\"https://stocknews.com/news/ci-president-trump-says-that-he-will-probably-sign-executive-order/\" target=\"_blank\">indicated </a>that he will probably sign an <a href=\"https://www.wsj.com/articles/trump-says-hell-work-with-democrats-on-health-care-1506538819?mod=e2tw\" target=\"_blank\">executive order</a> next week allowing people to buy health insurance across state lines. Conceptually, this should constrain or even reduce premiums due to increased competition.</li><li>Related tickers: (<a href='https://seekingalpha.com/symbol/CI' title='Cigna Corporation'>CI</a> <font color='red'>-0.2%</font>)(<a href='https://seekingalpha.com/symbol/AET' title='Aetna, Inc.'>AET</a> <font color='red'>-0.4%</font>)(<a href='https://seekingalpha.com/symbol/ANTM' title='Anthem, Inc.'>ANTM</a> <font color='green'>+0.3%</font>)(<a href='https://seekingalpha.com/symbol/UNH' title='UnitedHealth Group Inc.'>UNH</a> <font color='green'>+0.1%</font>)</li></ul><div class=\"tiny-share-widget\" data-id=\"3297949\" data-linked=\"Health insurers under pressure on looming Trump order allowing interstate purchase of insurance\" data-tweet=\"$CI $CI $AET - Health insurers under pressure on looming Trump order allowing interstate purchase of insurance https://seekingalpha.com/news/3297949-health-insurers-under-pressure-on-looming-trump-order-allowing-interstate-purchase-of?source=tweet\" data-url=\"https://seekingalpha.com/news/3297949-health-insurers-under-pressure-on-looming-trump-order-allowing-interstate-purchase-of\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:11 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>51&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3297948\" data-ts=\"1506531988\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WOR\" target=\"_blank\">WOR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3297948-worthington-ups-buyback-authorization-additional-6_8m-shares\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Worthington ups buyback authorization by additional 6.8M shares</a></h4><ul>     <li>Worthington Industries (<a href='https://seekingalpha.com/symbol/WOR' title='Worthington Industries, Inc.'>WOR</a> <font color='red'>-6.7%</font>) declares a $0.21/share quarterly <a href=\"https://seekingalpha.com/news/3297941-worthington-declares-0_21-dividend\" target=\"_blank\">dividend</a> and authorizes the repurchase of as much as an additional ~6.83M shares.</li><li>The move raises the total number of WOR common shares available for repurchase to 10M.</li><li>Shares are still lower after reporting <a href=\"https://seekingalpha.com/news/3297896-worthington-minus-6-percent-earnings-miss-automotive-sees-softening\" target=\"_blank\">disappointing quarterly earnings</a> but have bounced a bit higher.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3297948\" data-linked=\"Worthington ups buyback authorization by additional 6.8M shares\" data-tweet=\"$WOR - Worthington ups buyback authorization by additional 6.8M shares https://seekingalpha.com/news/3297948-worthington-ups-buyback-authorization-additional-6_8m-shares?source=tweet\" data-url=\"https://seekingalpha.com/news/3297948-worthington-ups-buyback-authorization-additional-6_8m-shares\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:06 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3297945\" data-ts=\"1506531570\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3297945-financials-top-5-gainers-losers-of-1-00-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Financials - Top 5 Gainers / Losers as of 1:00 PM</a></h4><ul><li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/GROW' title='U.S. Global Investors, Inc.'>GROW</a> <font color='green'>+8%</font>. <a href='https://seekingalpha.com/symbol/CCCR-OLD' title='China Commercial Credit'>CCCR-OLD</a> <font color='green'>+6%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/ATLC' title='Atlanticus Holdings Corp.'>ATLC</a> <font color='red'>-11%</font>. <a href='https://seekingalpha.com/symbol/FANH' title='Fanhua Inc.'>FANH</a> <font color='red'>-11%</font>. <a href='https://seekingalpha.com/symbol/PN' title='Patriot National, Inc.'>PN</a> <font color='red'>-8%</font>. <a href='https://seekingalpha.com/symbol/RLGY' title='Realogy Holdings'>RLGY</a> <font color='red'>-7%</font>. <a href='https://seekingalpha.com/symbol/FBP' title='First BanCorp'>FBP</a> <font color='red'>-6%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3297945\" data-linked=\"Financials - Top 5 Gainers / Losers as of 1:00 PM\" data-tweet=\"$GROW $CCCR-OLD $ATLC - Financials - Top 5 Gainers / Losers as of 1:00 PM https://seekingalpha.com/news/3297945-financials-top-5-gainers-losers-of-1-00-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3297945-financials-top-5-gainers-losers-of-1-00-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:59 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3297942\" data-ts=\"1506531272\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AEMD\" target=\"_blank\">AEMD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3297942-aethlon-completes-round-trip-and-down-20\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Aethlon completes round trip and then some, down 20%</a></h4><ul><li>Thinly traded nano cap Aethlon Medical (<a href='https://seekingalpha.com/symbol/AEMD' title='Aethlon Medical, Inc.'>AEMD</a> <font color='red'>-19.6%</font>) continues its slide on almost a 5x surge in volume. After touching $3.85 on September 12, shares have retraced almost 70%.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3294819-fda-designates-aethlon-hemopurifier-accelerated-review-shares-ahead-35-percent-premarket\" target=\"_blank\">FDA designates Aethlon' Hemopurifier for accelerated review; shares ahead 35% premarket</a> (Sept. 12)</li></ul><div class=\"tiny-share-widget\" data-id=\"3297942\" data-linked=\"Aethlon completes round trip and then some, down 20%\" data-tweet=\"$AEMD - Aethlon completes round trip and then some, down 20% https://seekingalpha.com/news/3297942-aethlon-completes-round-trip-and-down-20?source=tweet\" data-url=\"https://seekingalpha.com/news/3297942-aethlon-completes-round-trip-and-down-20\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:54 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3297939\" data-ts=\"1506530746\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3297939-midday-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Midday Gainers / Losers</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/IMNP' title='Immune Pharmaceuticals Inc.'>OTCQB:IMNP</a> <font color='green'>+40%</font>. <a href='https://seekingalpha.com/symbol/MTSL' title='MER Telemanagement Solutions Ltd.'>MTSL</a> <font color='green'>+27%</font>. <a href='https://seekingalpha.com/symbol/ICAD' title='iCAD, Inc.'>ICAD</a> <font color='green'>+26%</font>. <a href='https://seekingalpha.com/symbol/OSTK' title='Overstock.com, Inc.'>OSTK</a> <font color='green'>+18%</font>. <a href='https://seekingalpha.com/symbol/MARK' title='Remark Holdings, Inc.'>MARK</a> <font color='green'>+17%</font>. <a href='https://seekingalpha.com/symbol/OMNT' title='Ominto, Inc.'>OTCPK:OMNT</a> <font color='green'>+18%</font>. <a href='https://seekingalpha.com/symbol/BLPH' title='Bellerophon Therapeutics'>BLPH</a> <font color='green'>+15%</font>. <a href='https://seekingalpha.com/symbol/BGNE' title='BeiGene'>BGNE</a> <font color='green'>+13%</font>. <a href='https://seekingalpha.com/symbol/DTRM' title='Determine, Inc.'>OTC:DTRM</a> <font color='green'>+12%</font>. <a href='https://seekingalpha.com/symbol/PRTO' title='Proteon Therapeutics'>PRTO</a> <font color='green'>+12%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/TANH' title='Tantech Holdings'>TANH</a> <font color='red'>-34%</font>. <a href='https://seekingalpha.com/symbol/AEMD' title='Aethlon Medical, Inc.'>AEMD</a> <font color='red'>-19%</font>. <a href='https://seekingalpha.com/symbol/KRNT' title='Kornit Digital'>KRNT</a> <font color='red'>-18%</font>. <a href='https://seekingalpha.com/symbol/VERI' title='Veritone'>VERI</a> <font color='red'>-17%</font>. <a href='https://seekingalpha.com/symbol/BW' title='Babcock & Wilcox Enterprises, Inc.'>BW</a> <font color='red'>-17%</font>. <a href='https://seekingalpha.com/symbol/TTS' title='Tile Shop Holdings, Inc.'>TTS</a> <font color='red'>-17%</font>. <a href='https://seekingalpha.com/symbol/VNET' title='21Vianet Group'>VNET</a> <font color='red'>-15%</font>. <a href='https://seekingalpha.com/symbol/ROSG-OLD' title='Rosetta Genomics Ltd.'>ROSG-OLD</a> <font color='red'>-14%</font>. <a href='https://seekingalpha.com/symbol/SYRS' title='Syros Pharmaceuticals'>SYRS</a> <font color='red'>-12%</font>. <a href='https://seekingalpha.com/symbol/TAHO' title='Tahoe Resources Inc.'>TAHO</a> <font color='red'>-12%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3297939\" data-linked=\"Midday Gainers / Losers\" data-tweet=\"$IMNPQ $MTSL $ICAD - Midday Gainers / Losers https://seekingalpha.com/news/3297939-midday-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3297939-midday-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:45 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3297930\" data-ts=\"1506528050\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3297930-consumer-top-gainers-losers-of-12-00-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Consumer - Top Gainers / Losers as of 12:00 pm</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/JAKK' title='JAKKS Pacific, Inc.'>JAKK</a> <font color='green'>+7%</font>. <a href='https://seekingalpha.com/symbol/REV' title='Revlon, Inc.'>REV</a> <font color='green'>+5%</font>. <a href='https://seekingalpha.com/symbol/FTFT' title='Future Fintech Group Inc'>FTFT</a> <font color='green'>+5%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/CLXT' title='Calyxt, Inc.'>CLXT</a> <font color='red'>-8%</font>. <a href='https://seekingalpha.com/symbol/PME' title='Pingtan Marine Enterprise Ltd.'>PME</a> <font color='red'>-6%</font>. <a href='https://seekingalpha.com/symbol/NTZ' title='Natuzzi S.p.A.'>NTZ</a> <font color='red'>-6%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3297930\" data-linked=\"Consumer - Top Gainers / Losers as of 12:00 pm\" data-tweet=\"$JAKK $REV $FTFT - Consumer - Top Gainers / Losers as of 12:00 pm https://seekingalpha.com/news/3297930-consumer-top-gainers-losers-of-12-00-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3297930-consumer-top-gainers-losers-of-12-00-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:00 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3297926\" data-ts=\"1506527718\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3297926-canadian-stocks-higher-loonie-lower-poloz-dials-back-hawkishness\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Canadian stocks higher, loonie lower as Poloz dials back hawkishness</a></h4><ul><li>It's been a steady stream of hawkish talk from the Bank of Canada over the past several weeks, including an unexpected rate hike earlier this month.</li><li>Governor Stephen Poloz dials that down a bit this morning,<a href=\"http://www.bankofcanada.ca/2017/09/meaning-data-dependence-economic-progress-report/\" target=\"_blank\"> telling an audience</a> there's no predetermined path for rates.</li><li>Poloz: \"Monetary policy will be particularly data dependent in these circumstances and, as always, we could still be surprised in either direction.\"</li><li>The TSX has moved to a session high,&nbsp;<font color='green'>up 0.3%</font>, and the loonie to a session low,&nbsp;<font color='red'>down 0.6%</font>&nbsp;vs. the greenback.</li><li>ETFs: <a href='https://seekingalpha.com/symbol/EWC' title='iShares MSCI Canada ETF'>EWC</a>, <a href='https://seekingalpha.com/symbol/FXC' title='CurrencyShares Canadian Dollar Trust ETF'>FXC</a>, <a href='https://seekingalpha.com/symbol/CNDA' title='IQ Canada Small Cap ETF'>CNDA</a>, <a href='https://seekingalpha.com/symbol/EWCS' title='iShares MSCI Canada Small Cap Index ETF'>EWCS</a>, <a href='https://seekingalpha.com/symbol/QCAN' title='SPDR MSCI Canada Quality Mix ETF'>QCAN</a>, <a href='https://seekingalpha.com/symbol/FCAN' title='First Trust Canada AlphaDex ETF'>FCAN</a>, <a href='https://seekingalpha.com/symbol/HEWC' title='iShares Currency Hedged MSCI Canada ETF'>HEWC</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3297926\" data-linked=\"Canadian stocks higher, loonie lower as Poloz dials back hawkishness\" data-tweet=\"$EWC $FXC $CNDA - Canadian stocks higher, loonie lower as Poloz dials back hawkishness https://seekingalpha.com/news/3297926-canadian-stocks-higher-loonie-lower-poloz-dials-back-hawkishness?source=tweet\" data-url=\"https://seekingalpha.com/news/3297926-canadian-stocks-higher-loonie-lower-poloz-dials-back-hawkishness\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:55 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3297925\" data-ts=\"1506527092\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BMS\" target=\"_blank\">BMS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3297925-report-bemis-not-in-deal-talks-amcor\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Report: Bemis not in deal talks with Amcor</a></h4><ul>     <li>Bemis (<a href='https://seekingalpha.com/symbol/BMS' title='Bemis Company, Inc.'>BMS</a> <font color='red'>-3.7%</font>) is sharply lower in today's trade amid speculation that the company is <a href=\"https://www.streetinsider.com/Trader+Talk/UPDATE%3A+Bemis+%28BMS%29+Quickly+Falls+to+Session+Low%3B+Amcor+is+Said+Not+Currently+in+Talks+with+Bemis+-+Bloomberg%2C+Citing+DealReporter/13333523.html\" target=\"_blank\">not in deal discussions</a> with Amcor (<a href='https://seekingalpha.com/symbol/AMCRY' title='Amcor Ltd. ADR'>OTCPK:AMCRY</a> <font color='red'>-0.6%</font>), according to <em>DealReporter</em>.</li>     <li>Amcor was considering a takeover of its packaging company rival, according to reports <a href=\"https://seekingalpha.com/news/3294242-bemis-plus-10-percent-amcor-reportedly-explores-takeover\" target=\"_blank\">earlier this month</a>.</li>     <li>A sector advisor cited by <em>DealReporter</em> says while Amcor \"might be an opportunistic buyer\" of BMS, it is \"unlikely to be aggressive on price.\"</li></ul><div class=\"tiny-share-widget\" data-id=\"3297925\" data-linked=\"Report: Bemis not in deal talks with Amcor\" data-tweet=\"$BMS $AMCR - Report: Bemis not in deal talks with Amcor https://seekingalpha.com/news/3297925-report-bemis-not-in-deal-talks-amcor?source=tweet\" data-url=\"https://seekingalpha.com/news/3297925-report-bemis-not-in-deal-talks-amcor\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:44 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3297923\" data-ts=\"1506525964\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SCG\" target=\"_blank\">SCG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3297923-lawsuit-claims-scana-execs-collected-big-bonuses-even-project-collapsed\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Lawsuit claims SCANA execs collected big bonuses even as project collapsed</a></h4><ul>     <li>A newly filed federal lawsuit <a href=\"http://www.wistv.com/story/36459646/federal-lawsuit-utility-execs-collected-big-bonuses-as-vc-summer-collapsed\" target=\"_blank\">alleges</a> that SCANA (<a href='https://seekingalpha.com/symbol/SCG' title='SCANA Corporation'>SCG</a> <font color='red'>-6.2%</font>) and partner Santee Cooper \"actively concealed\" or  publicly minimized a substantial risk that the V.C. Summer nuclear expansion project in South Carolina could fail, and says utility executives were earning big performance bonuses even as the project was falling apart.</li>     <li>The suit says SCG knew or should have known the company's bottom line would be enhanced regardless of whether the reactors actually were finished, and notes the \"handsome bonuses\" paid to top utility officials even as the project \"veered toward abandonment.\"</li><li>The suit comes amid federal and state investigations into SCG's handling of the canceled project.</li></ul><div class=\"tiny-share-widget\" data-id=\"3297923\" data-linked=\"Lawsuit claims SCANA execs collected big bonuses even as project collapsed\" data-tweet=\"$SCG - Lawsuit claims SCANA execs collected big bonuses even as project collapsed https://seekingalpha.com/news/3297923-lawsuit-claims-scana-execs-collected-big-bonuses-even-project-collapsed?source=tweet\" data-url=\"https://seekingalpha.com/news/3297923-lawsuit-claims-scana-execs-collected-big-bonuses-even-project-collapsed\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:26 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3297920\" data-ts=\"1506525317\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3297920-surging-interest-rates-boost-financials\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Surging interest rates boost financials</a></h4><ul><li>The Dow and S&amp;P 500 are about flat, but the <a href='https://seekingalpha.com/symbol/XLF' title='Financial Select Sector SPDR ETF'>XLF</a>, <a href='https://seekingalpha.com/symbol/KRE' title='SPDR S&P Regional Banking ETF'>KRE</a>, and <a href='https://seekingalpha.com/symbol/KBE' title='SPDR S&P Bank ETF'>KBE</a> are all&nbsp;<font color='green'>ahead by 1%&nbsp;</font>or more as the 10-year Treasury yield jumps six basis points to 2.30%.</li><li>The rise in interest rates comes as the August durable good report printed well ahead of expectations. The housing market, however, looks to be stalling based on the latest NAR report on pending home sales. <a href=\"https://seekingalpha.com/news/3297909-tax-plan-details-begin-leak\" target=\"_blank\">Details of the GOP tax </a>reform plan are also leaking out - including a big cut in corporate tax rates, a doubling in the standard deduction, and the elimination of the AMT. Congress will of course have its say.</li><li>ETFs: <a href='https://seekingalpha.com/symbol/XLF' title='Financial Select Sector SPDR ETF'>XLF</a>, <a href='https://seekingalpha.com/symbol/FAS' title='Direxion Daily Financial Bull 3x Shares ETF'>FAS</a>, <a href='https://seekingalpha.com/symbol/FAZ' title='Direxion Daily Financial Bear 3x Shares ETF'>FAZ</a>, <a href='https://seekingalpha.com/symbol/VFH' title='Vanguard Financials ETF'>VFH</a>, <a href='https://seekingalpha.com/symbol/UYG' title='ProShares Ultra Financials ETF'>UYG</a>, <a href='https://seekingalpha.com/symbol/IYF' title='iShares U.S. Financials ETF'>IYF</a>, <a href='https://seekingalpha.com/symbol/FNCL' title='Fidelity MSCI Financials Index ETF'>FNCL</a>, <a href='https://seekingalpha.com/symbol/BTO' title='John Hancock Financial Opportunity Fund'>BTO</a>, <a href='https://seekingalpha.com/symbol/IYG' title='iShares U.S. Financial Services ETF'>IYG</a>, <a href='https://seekingalpha.com/symbol/FXO' title='First Trust Financials AlphaDEX ETF'>FXO</a>, <a href='https://seekingalpha.com/symbol/SEF' title='ProShares Short Financials ETF'>SEF</a>, <a href='https://seekingalpha.com/symbol/RYF' title='Guggenheim S&P Equal Weight Financial ETF'>RYF</a>, <a href='https://seekingalpha.com/symbol/FINU' title='ProShares UltraPro Financials ETF'>FINU</a>, <a href='https://seekingalpha.com/symbol/FINZ' title='ProShares UltraPro Short Financials ETF'>FINZ</a>, <a href='https://seekingalpha.com/symbol/RWW' title='Oppenheimer Financials Sector Revenue ETF'>RWW</a>, <a href='https://seekingalpha.com/symbol/FAZZ' title='Direxion Daily Financial Bear 1x Shares ETF'>FAZZ</a>, <a href='https://seekingalpha.com/symbol/JHMF' title='John Hancock Multifactor Financials ETF'>JHMF</a>, <a href='https://seekingalpha.com/symbol/FNCF' title='iShares Edge MSCI Multifactor Financials ETF'>FNCF</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3297920\" data-linked=\"Surging interest rates boost financials\" data-tweet=\"$XLF $KRE $KBE - Surging interest rates boost financials https://seekingalpha.com/news/3297920-surging-interest-rates-boost-financials?source=tweet\" data-url=\"https://seekingalpha.com/news/3297920-surging-interest-rates-boost-financials\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:15 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3297917\" data-ts=\"1506524791\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NVDA\" target=\"_blank\">NVDA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3297917-nvidia-announces-server-partnerships-for-v100-accelerators\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Nvidia announces server partnerships for V100 accelerators</a></h4><ul><li>        Nvidia (NASDAQ:<a href='https://seekingalpha.com/symbol/NVDA' title='NVIDIA Corporation'>NVDA</a>) <a href=\"http://nvidianews.nvidia.com/news/world-s-largest-server-companies-announce-nvidia-volta-systems-supercharged-for-ai\" target=\"_blank\">announces</a> partnering with industry leaders for servers based on the company&rsquo;s Tesla V100 accelerators, advanced GPUs for compute-intensive workloads like artificial intelligence.&nbsp;</li><li>               Partners include Dell EMC, Hewlett Packard Enterprise (NYSE:<a href='https://seekingalpha.com/symbol/HPE' title='Hewlett Packard Enterprise'>HPE</a>), IBM (NYSE:<a href='https://seekingalpha.com/symbol/IBM' title='International Business Machines Corporation'>IBM</a>), and Supermicro.&nbsp;</li><li>               The V100 GPUs feature more than 120 teraflops of deep learning performance with a single GPU equivalent to the performance of 100 CPUs.&nbsp;</li><li>               Nvidia shares are&nbsp;<font color='green'>up 1.06%</font>. &nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</li><li>Previously: <a href=\"https://seekingalpha.com/news/3297702-bloomberg-tesla-replacing-nvidia-intel-infotainment-components\" target=\"_blank\">Bloomberg: Tesla replacing Nvidia with Intel for infotainment components</a> (Sept. 26)</li></ul><div class=\"tiny-share-widget\" data-id=\"3297917\" data-linked=\"Nvidia announces server partnerships for V100 accelerators\" data-tweet=\"$NVDA $NVDA $HPE - Nvidia announces server partnerships for V100 accelerators https://seekingalpha.com/news/3297917-nvidia-announces-server-partnerships-for-v100-accelerators?source=tweet\" data-url=\"https://seekingalpha.com/news/3297917-nvidia-announces-server-partnerships-for-v100-accelerators\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:06 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>28&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3297890\" data-ts=\"1506524459\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3297890-healthcare-top-5-gainers-losers-of-11-00\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Healthcare - Top 5 Gainers / Losers as of 11:00 am</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/IMNP' title='Immune Pharmaceuticals Inc.'>OTCQB:IMNP</a> <font color='green'>+35%</font>. <a href='https://seekingalpha.com/symbol/CEMP' title='Cempra, Inc.'>CEMP</a> <font color='green'>+15%</font>. <a href='https://seekingalpha.com/symbol/BGNE' title='BeiGene'>BGNE</a> <font color='green'>+13%</font>. <a href='https://seekingalpha.com/symbol/OCRX' title='Ocera Therapeutics, Inc.'>OCRX</a> <font color='green'>+12%</font>. <a href='https://seekingalpha.com/symbol/BLPH' title='Bellerophon Therapeutics'>BLPH</a> <font color='green'>+12%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/SYRS' title='Syros Pharmaceuticals'>SYRS</a> <font color='red'>-14%</font>. <a href='https://seekingalpha.com/symbol/AEMD' title='Aethlon Medical, Inc.'>AEMD</a> <font color='red'>-10%</font>. <a href='https://seekingalpha.com/symbol/ITCI' title='Intra-Cellular Therapies Inc.'>ITCI</a> <font color='red'>-9%</font>. <a href='https://seekingalpha.com/symbol/ARDM' title='Aradigm Corp.'>OTC:ARDM</a> <font color='red'>-8%</font>. <a href='https://seekingalpha.com/symbol/CLRB' title='Cellectar Biosciences, Inc.'>CLRB</a> <font color='red'>-7%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3297890\" data-linked=\"Healthcare - Top 5 Gainers / Losers as of 11:00 am\" data-tweet=\"$IMNPQ $CEMP $BGNE - Healthcare - Top 5 Gainers / Losers as of 11:00 am https://seekingalpha.com/news/3297890-healthcare-top-5-gainers-losers-of-11-00?source=tweet\" data-url=\"https://seekingalpha.com/news/3297890-healthcare-top-5-gainers-losers-of-11-00\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:00 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3297906\" data-ts=\"1506523847\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CLRB\" target=\"_blank\">CLRB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3297906-cellectars-clr-131-shows-positive-action-highest-dose-in-early-stage-multiple-myeloma-study\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cellectar&#39;s CLR 131 shows positive action at highest dose in early-stage multiple myeloma study</a></h4><ul><li>Cellectar Biosciences (<a href='https://seekingalpha.com/symbol/CLRB' title='Cellectar Biosciences, Inc.'>CLRB</a> <font color='red'>-8.8%</font>) reports <a href=\"https://seekingalpha.com/pr/16952465-cellectar-biosciences-reports-cohort-four-data-partial-response-relapsed-refractory-multiple\" target=\"_blank\">new data</a> from its ongoing Phase 1 study assessing lead candidate CLR 131 in patients with relapsed/refractory multiple myeloma. The primary objective is to identify the highest tolerated dose, now at 31.25 mCi/m2 as determined by the Data Monitoring Committee.</li><li>In three evaluable patients in the highest dose cohort, two had stable disease and one experienced a partial response. All three were heavily pretreated, one with seven prior lines of therapy.</li><li>CEO Jim Caruso says, &ldquo;The encouraging data from Cohort 4 including the partial response and the DMC&rsquo;s determination that the 31.25 mCi/m<sup>2</sup>&nbsp;of CLR 131 was safe is impressive in light of the highly advanced disease and heavily pretreated patients within the cohort. Given the preclinical and clinical data results we&rsquo;ve seen to date, the company intends to advance the compound into a fifth cohort using a multi-dose regimen.&rdquo;</li><li>CLR 131 is a&nbsp;<a href=\"http://cellectar.com/pdc-platform/\" target=\"_blank\">phospholipid ether-drug conjugate</a>&nbsp;that selectively delivers a cytotoxic payload to cancer cells.</li><li>Investors are behaving like they were expecting more, shares are down modestly higher volume.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3286832-cellectar-bios-lead-candidate-clr-131-achieves-median-os-22_5-months-single-infusion-multiple\" target=\"_blank\">Cellectar Bio's lead candidate CLR 131 achieves median OS of 22.5 months after single infusion in multiple myeloma patients; shares ahead 28% premarket</a> (Aug. 8)</li></ul><div class=\"tiny-share-widget\" data-id=\"3297906\" data-linked=\"Cellectar&#39;s CLR 131 shows positive action at highest dose in early-stage multiple myeloma study\" data-tweet=\"$CLRB - Cellectar&#39;s CLR 131 shows positive action at highest dose in early-stage multiple myeloma study https://seekingalpha.com/news/3297906-cellectars-clr-131-shows-positive-action-highest-dose-in-early-stage-multiple-myeloma-study?source=tweet\" data-url=\"https://seekingalpha.com/news/3297906-cellectars-clr-131-shows-positive-action-highest-dose-in-early-stage-multiple-myeloma-study\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:50 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3297907\" data-ts=\"1506523624\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VNET\" target=\"_blank\">VNET</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3297907-21vianet-divests-two-business-units\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">21Vianet divests two business units</a></h4><ul><li>        21Vianet Group (NASDAQ:<a href='https://seekingalpha.com/symbol/VNET' title='21Vianet Group'>VNET</a>) <a href=\"https://seekingalpha.com/pr/16952267-21vianet-announces-completion-divesture-two-business-units\" target=\"_blank\">announces</a> divesting two units within its Managed Network Services business. &nbsp;</li><li>        The company transferred 66.67% of its equity interest in 6 wholly-owned companies in the content delivery network services, hosted area network services, and route optimization businesses that add up to form the WiFire Entities. </li><li>The WiFire Entities bundle was sold to Yuanchuang Technology Development Co. for a &ldquo;nominal consideration.&rdquo;&nbsp;</li><li>        21Vianet also transfers 2 shares of Sichuan Aipu Network to Aipu director and Co-CEO Jian Li or a nominal consideration</li><li>        21Vianet shares are&nbsp;<font color='red'>down 12.66%.</font>&nbsp;</li></ul><div class=\"tiny-share-widget\" data-id=\"3297907\" data-linked=\"21Vianet divests two business units\" data-tweet=\"$VNET - 21Vianet divests two business units https://seekingalpha.com/news/3297907-21vianet-divests-two-business-units?source=tweet\" data-url=\"https://seekingalpha.com/news/3297907-21vianet-divests-two-business-units\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:47 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3297904\" data-ts=\"1506522730\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SPWR\" target=\"_blank\">SPWR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3297904-sunpower-cut-to-sell-rating-morgan-stanley-regardless-of-trade-ruling\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">SunPower cut to sell rating at Morgan Stanley regardless of trade ruling</a></h4><ul>     <li>SunPower (<a href='https://seekingalpha.com/symbol/SPWR' title='SunPower Corporation'>SPWR</a> <font color='green'>+2.3%</font>) is higher despite receiving a <a href=\"http://thefly.com/thestreet/realmoney/index.php/SPWRid2614707/SPWR-SunPower-downgraded-to-Underweight-from-Equal-Weight-at-Morgan-Stanley\" target=\"_blank\">downgrade</a> to Underweight from Equal Weight with a $6 price target at Morgan Stanley, which says it is cautious on the shares even without a negative trade ruling.</li><li>Stanley foresees overcapacity in the solar sector worsening through 2019, with module production capacity exceeding demand by ~35% in 2018-19 and likely leading to lower solar panel prices and thin margins.</li><li>SPWR also would be hurt by any penalties imposed by the U.S. government in the ongoing Section 201 trade case, Stanley says, as a majority of its revenues are generated in the U.S. and its panels are manufactured overseas.</li><li>Any tariffs imposed by Pres. Trump in the Section 201 case could cause SPWR's EBITDA to drop $80M-$100M in both 2018 and 2019, the firm says.</li></ul><div class=\"tiny-share-widget\" data-id=\"3297904\" data-linked=\"SunPower cut to sell rating at Morgan Stanley regardless of trade ruling\" data-tweet=\"$SPWR - SunPower cut to sell rating at Morgan Stanley regardless of trade ruling https://seekingalpha.com/news/3297904-sunpower-cut-to-sell-rating-morgan-stanley-regardless-of-trade-ruling?source=tweet\" data-url=\"https://seekingalpha.com/news/3297904-sunpower-cut-to-sell-rating-morgan-stanley-regardless-of-trade-ruling\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:32 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3297903\" data-ts=\"1506522659\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3297903-eia-petroleum-inventories\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">EIA Petroleum Inventories</a></h4><ul>     <li><a href=\"http://ir.eia.gov/wpsr/wpsrsummary.pdf\" target=\"_blank\">EIA Petroleum Inventories</a>: Crude <strong>-1.8</strong><strong>M</strong> barrels vs. +3.4M consensus, +4.6M last week.</li><li>Gasoline<strong>&nbsp;+1.1M</strong> barrels vs. -0.9M consensus, -2.1M last week.</li><li>Distillates<strong> -0.8M</strong> barrels vs. -2.2M consensus, -5.7M last week.</li><li>Futures&nbsp;<font color='green'>+0.25%</font>&nbsp;to $52.01.</li><li>ETFs:<a href='https://seekingalpha.com/symbol/USO' title='The United States Oil ETF, LP'>USO</a>, <a href='https://seekingalpha.com/symbol/OIL' title='iPath S&P Crude Oil Total Return Index ETN'>OIL</a>, <a href='https://seekingalpha.com/symbol/UCO' title='ProShares Ultra Bloomberg Crude Oil ETF'>UCO</a>, <a href='https://seekingalpha.com/symbol/SCO' title='ProShares UltraShort Bloomberg Crude Oil ETF'>SCO</a>, <a href='https://seekingalpha.com/symbol/BNO' title='The United States Brent Oil ETF, LP'>BNO</a>, <a href='https://seekingalpha.com/symbol/DTO' title='DB Crude Oil Double Short ETN'>DTO</a>, <a href='https://seekingalpha.com/symbol/DBO' title='PowerShares DB Oil ETF'>DBO</a>, <a href='https://seekingalpha.com/symbol/USL' title='The United States 12 Month Oil ETF, LP'>USL</a>, <a href='https://seekingalpha.com/symbol/DNO' title='The United States Short Oil ETF, LP'>DNO</a>, <a href='https://seekingalpha.com/symbol/SZO' title='DB Crude Oil Short ETN'>SZO</a>, <a href='https://seekingalpha.com/symbol/OLO' title='DB Crude Oil Long ETN'>OLO</a>, <a href='https://seekingalpha.com/symbol/OLEM' title='iPath Pure Beta Crude Oil ETN'>OLEM</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3297903\" data-linked=\"EIA Petroleum Inventories\" data-tweet=\"$USO $OIL $UCO - EIA Petroleum Inventories https://seekingalpha.com/news/3297903-eia-petroleum-inventories?source=tweet\" data-url=\"https://seekingalpha.com/news/3297903-eia-petroleum-inventories\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:30 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>98&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3297901\" data-ts=\"1506522267\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HUBS\" target=\"_blank\">HUBS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3297901-hubspot-announces-new-shopify-integration\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">HubSpot announces new Shopify integration</a></h4><ul><li>        HubSpot (NYSE:<a href='https://seekingalpha.com/symbol/HUBS' title='HubSpot, Inc.'>HUBS</a>) <a href=\"https://seekingalpha.com/pr/16951931-hubspot-launches-native-ecommerce-integration-shopify\" target=\"_blank\">announces</a> a new integration with Shopify that allows its customers to bring Shopify (NYSE:<a href='https://seekingalpha.com/symbol/SHOP' title='Shopify'>SHOP</a>) and its data onto the HubSpot platform.</li><li>               The integration provides advanced customer resource management functionality and helps ecommerce marketers with specific tasks.&nbsp;</li><li>               The Shopify integration is currently in limited beta with the wide launch coming soon.&nbsp;</li><li>HubSpot shares are&nbsp;<font color='green'>up 9.15%</font>.&nbsp;</li><li>Shopify shares are&nbsp;<font color='green'>up 1.38%</font>.&nbsp;&nbsp;</li></ul><div class=\"tiny-share-widget\" data-id=\"3297901\" data-linked=\"HubSpot announces new Shopify integration\" data-tweet=\"$HUBS $HUBS $SHOP - HubSpot announces new Shopify integration https://seekingalpha.com/news/3297901-hubspot-announces-new-shopify-integration?source=tweet\" data-url=\"https://seekingalpha.com/news/3297901-hubspot-announces-new-shopify-integration\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:24 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3297896\" data-ts=\"1506521292\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WOR\" target=\"_blank\">WOR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3297896-worthingtonminus-6-on-earnings-miss-automotive-sees-softening\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Worthington -6% on earnings miss; automotive sees some softening</a></h4><ul>     <li>Worthington Industries (<a href='https://seekingalpha.com/symbol/WOR' title='Worthington Industries, Inc.'>WOR</a> <font color='red'>-6.3%</font>) is sharply lower in early trading after missing expectations for <a href=\"https://seekingalpha.com/news/3297836-worthington-misses-0_09-misses-revenue\" target=\"_blank\">FQ1 earnings</a> and revenues.</li>     <li>WOR says the quarter saw increases in heavy truck and agriculture volumes but \"some softening\" in its automotive business, while its cylinders business enjoyed increased demand for oil and gas equipment.</li>     <li>FQ1 gross margin fell $14.5M Y/Y to $132.8M as contributions from the Amtrol acquidition were more than offset by lower spreads in steel processing, down $23.4M from the year-ago quarter when rising steel prices led to significant inventory holding gains.</li>     <li>Total debt was $780M at the end of FQ1, up $202M from  the end of the prior quarter, due to the issuance of notes and the Amtrol acquisition.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3297896\" data-linked=\"Worthington -6% on earnings miss; automotive sees some softening\" data-tweet=\"$WOR - Worthington -6% on earnings miss; automotive sees some softening https://seekingalpha.com/news/3297896-worthingtonminus-6-on-earnings-miss-automotive-sees-softening?source=tweet\" data-url=\"https://seekingalpha.com/news/3297896-worthingtonminus-6-on-earnings-miss-automotive-sees-softening\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:08 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3297895\" data-ts=\"1506521266\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BABA\" target=\"_blank\">BABA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3297895-alibaba-pushes-gaming-new-unit-ejoy-purchase\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Alibaba pushes into gaming with new unit, Ejoy purchase</a></h4><ul>   <li>Alibaba (<a href=\"http://seekingalpha.com/symbol/BABA\" target=\"_blank\">BABA</a> <font color='green'>+2.4%</font>) is pushing hard into the lucrative gaming sector, buying online game company Ejoy and <a href=\"https://www.chinamoneynetwork.com/2017/09/27/alibaba-acquires-gaming-firm-ejoy-expand-online-gaming-business\" target=\"_blank\">setting up a business unit</a> to expand into games.</li>    <li>The move comes via its Digital Media and Entertainment Group, which will have a pair of departments: online platform, and interactive entertainment.</li>    <li>China's online gaming industry was worth 78.32B yuan (about $11.8B) as of last year, and total revenues are expected to grow nearly 89% this year. It's catering to a universe of 523M active users, IIMedia Research says.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3297895\" data-linked=\"Alibaba pushes into gaming with new unit, Ejoy purchase\" data-tweet=\"$BABA - Alibaba pushes into gaming with new unit, Ejoy purchase https://seekingalpha.com/news/3297895-alibaba-pushes-gaming-new-unit-ejoy-purchase?source=tweet\" data-url=\"https://seekingalpha.com/news/3297895-alibaba-pushes-gaming-new-unit-ejoy-purchase\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:07 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>16&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3297894\" data-ts=\"1506521153\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/OSTK\" target=\"_blank\">OSTK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3297894-overstock-com-pops-off-ico-buzz\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Overstock.com pops off ICO buzz</a></h4><ul> <li>Overstock.com (NASDAQ:<a href='https://seekingalpha.com/symbol/OSTK' title='Overstock.com, Inc.'>OSTK</a>) <font color='green'>rallies 6.61%</font> off of today's announcement of a blockchain technology move with JV partners.</li> <li>The company is jumping right into the ICO market with a plan to launch the only SEC-compliant token trading venue.</li> <li>Need a primer on what an ICO is exactly? Seeking Alpha contributor Danile Carlson has you covered <a href=\"https://seekingalpha.com/article/4087841-making-sense-coin-offerings\" target=\"_blank\">here</a>.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3297829-overstock-com-announces-blockchain-jv-move\" target=\"_blank\">Overstock.com announces blockchain JV move</a> (Sept. 27)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3297894\" data-linked=\"Overstock.com pops off ICO buzz\" data-tweet=\"$OSTK - Overstock.com pops off ICO buzz https://seekingalpha.com/news/3297894-overstock-com-pops-off-ico-buzz?source=tweet\" data-url=\"https://seekingalpha.com/news/3297894-overstock-com-pops-off-ico-buzz\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:05 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3297892\" data-ts=\"1506520938\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AZRX\" target=\"_blank\">AZRX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3297892-azurrx-bios-ms1819-sd-shows-treatment-effect-in-mid-stage-pancreatitis-study-shares-up\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">AzurRx Bio&#39;s MS1819-SD shows treatment effect in mid-stage pancreatitis study; shares up</a></h4><ul><li>Thinly traded nano cap AzurRx BioPharma (NASDAQ:<a href='https://seekingalpha.com/symbol/AZRX' title='AzurRX Biopharma'>AZRX</a>) is up&nbsp;<font color='green'>9%</font>&nbsp;on a 6x spike in volume, albeit on turnover of only 226K shares, in response to its <a href=\"https://seekingalpha.com/pr/16952437-azurrx-biopharma-mayoly-spindler-announce-positive-ms1819-sd-phase-ii-data-exocrine\" target=\"_blank\">announcement </a>of positive results from an Australia-based Phase 2a clinical trial assessing MS1819-SD in pancreatitis patients with exocrine pancreatic insufficiency.</li><li>Both clinical activity and dose response were observed. The highest dose cohort experienced a 21% improvement in coefficient of fat absorption &#40;CFA&#41; in evaluable patients. The maximum response was 57%. Favorable trends were observed on other endpoints.</li><li>No significant safety signals were observed.</li><li>MS1819 is a recombinant lipase derived from the yeast <em>Yarrowia Lipolytica</em>.</li><li>The company is developing the product with Laboratoires Mayoly Spindler under which AzurRx owns exclusive rights for North America.</li></ul><div class=\"tiny-share-widget\" data-id=\"3297892\" data-linked=\"AzurRx Bio&#39;s MS1819-SD shows treatment effect in mid-stage pancreatitis study; shares up\" data-tweet=\"$AZRX - AzurRx Bio&#39;s MS1819-SD shows treatment effect in mid-stage pancreatitis study; shares up https://seekingalpha.com/news/3297892-azurrx-bios-ms1819-sd-shows-treatment-effect-in-mid-stage-pancreatitis-study-shares-up?source=tweet\" data-url=\"https://seekingalpha.com/news/3297892-azurrx-bios-ms1819-sd-shows-treatment-effect-in-mid-stage-pancreatitis-study-shares-up\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:02 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3297883\" data-ts=\"1506520185\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AMZN\" target=\"_blank\">AMZN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3297883-amazon-gets-new-street-high-price-target\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Amazon gets new Street high price target</a></h4><ul><li>        Wells Fargo Securities <a href=\"https://www.cnbc.com/2017/09/27/amazon-gets-its-most-bullish-wall-street-call-yet-1400-price-forecast.html\" target=\"_blank\">raises</a> its Amazon (NASDAQ:<a href='https://seekingalpha.com/symbol/AMZN' title='Amazon.com, Inc.'>AMZN</a>) price target to a new Street high of $1,400.</li><li>               Analyst Ken Sena sees Amazon as one of the best-positioned companies to apply AI across new and multiple verticals. &nbsp;&nbsp;</li><li>               \"We see this lead in data, coupled with the company's edge in compute efficiency, as increasingly feeding insights into supply chain, for its retail, video, and other efforts, and through AWS, for its partners,\" writes Sena.&nbsp;</li><li>               Sena cites revenue potential in the cloud computing market that&rsquo;s expected to exceed $200B by 2020. Amazon holds a 46% market share with AWS. Apparel, groceries, and OTC medications offer another potential $130B market.&nbsp;</li><li>               Amazon shares are&nbsp;<font color='green'>up 1.12%</font>&nbsp;to $949.08.&nbsp;&nbsp;&nbsp;&nbsp;</li><li>Previously: <a href=\"https://seekingalpha.com/news/3297758-youtube-goes-dark-echo-show\" target=\"_blank\">YouTube goes dark on Echo Show</a> (Sept. 27)</li></ul><div class=\"tiny-share-widget\" data-id=\"3297883\" data-linked=\"Amazon gets new Street high price target\" data-tweet=\"$AMZN - Amazon gets new Street high price target https://seekingalpha.com/news/3297883-amazon-gets-new-street-high-price-target?source=tweet\" data-url=\"https://seekingalpha.com/news/3297883-amazon-gets-new-street-high-price-target\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:49 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>37&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3297873\" data-ts=\"1506518826\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NFLX\" target=\"_blank\">NFLX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3297873-netflix-makes-cut-in-wells-fargo-future-of-tech-call\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Netflix makes the cut in Wells Fargo future of tech call</a></h4><ul> <li>Wells Fargo jumps on the Netflix (NASDAQ:<a href='https://seekingalpha.com/symbol/NFLX' title='Netflix, Inc.'>NFLX</a>) bandwagon with an initiation at Outperform. A high-flying price target of $230 is set on the streamer.</li> <li>The investment firm made a broad call on the future of tech (Neural Networking Internet/AI) in which Netflix made the cut.</li> <li>NFLX <font color='green'>+0.84%</font> premarket to $180.89.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3297873\" data-linked=\"Netflix makes the cut in Wells Fargo future of tech call\" data-tweet=\"$NFLX - Netflix makes the cut in Wells Fargo future of tech call https://seekingalpha.com/news/3297873-netflix-makes-cut-in-wells-fargo-future-of-tech-call?source=tweet\" data-url=\"https://seekingalpha.com/news/3297873-netflix-makes-cut-in-wells-fargo-future-of-tech-call\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:27 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3297871\" data-ts=\"1506518761\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3297871-premarket-gainers-of-9-05\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket Gainers as of 9:05 am</a></h4><ul><li><a href='https://seekingalpha.com/symbol/IMNP' title='Immune Pharmaceuticals Inc.'>OTCQB:IMNP</a> <font color='green'>+52%</font>&nbsp;on <a href=\"https://seekingalpha.com/pr/16952301-immune-pharmaceuticals-announces-positive-results-ongoing-phase-2-trial-bertilimumab-bullous\" target=\"_blank\">positive</a> result of open-label phase 2 study of bertilimumab.</li><li><a href='https://seekingalpha.com/symbol/MARK' title='Remark Holdings, Inc.'>MARK</a> <font color='green'>+42%</font>.</li><li><a href='https://seekingalpha.com/symbol/AZRX' title='AzurRX Biopharma'>AZRX</a> <font color='green'>+27%</font>&nbsp;on <a href=\"https://seekingalpha.com/pr/16952437-azurrx-biopharma-mayoly-spindler-announce-positive-ms1819-sd-phase-ii-data-exocrine\" target=\"_blank\">positive</a> result from ongoing Phase IIa trial of MS1819-SD.</li><li><a href='https://seekingalpha.com/symbol/GNCA' title='Genocea Biosciences, Inc.'>GNCA</a> <font color='green'>+10%</font>.</li><li><a href='https://seekingalpha.com/symbol/CLSN' title='Celsion Corporation'>CLSN</a> <font color='green'>+9%</font>&nbsp;on <a href=\"https://seekingalpha.com/pr/16952539-celsion-provides-update-thermodox-phase-iii-optima-study-primary-liver-cancer\" target=\"_blank\">update</a> on ThermoDox in the phase III optima study of Primary liver cancer.</li><li><a href='https://seekingalpha.com/symbol/TEUM' title='Pareteum Corporation'>TEUM</a> <font color='green'>+9%</font>.</li><li><a href='https://seekingalpha.com/symbol/TRPX' title='Therapix Biosciences'>TRPX</a> <font color='green'>+8%</font>&nbsp;on&nbsp;<a href=\"https://seekingalpha.com/news/3297862-therapixs-low-dose-thc-drug-candidate-reverses-age-related-cognitive-impairment-animal-study\" target=\"_blank\">announcement&nbsp;</a>of positive preclinical results on Mild Cognitive Impairment candidate THX-ULD01, its ultra-low dose tetrahydrocannabinol drug.</li><li><a href='https://seekingalpha.com/symbol/CASC' title='Cascadian Therapeutics, Inc'>CASC</a> <font color='green'>+7%</font>&nbsp;on&nbsp;<a href=\"https://seekingalpha.com/news/3297822-cascadians-tucatinib-orphan-drug-u-s-her2-plus-crc-shares-ahead-7-percent-premarket\" target=\"_blank\">announcement&nbsp;</a>that the FDA has granted Orphan Drug status for Phase 2-stage tucatinib.</li><li><a href='https://seekingalpha.com/symbol/TWLO' title='Twilio'>TWLO</a> <font color='green'>+7%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3297815-mufg-analyst-says-buy-twilio-selloff\" target=\"_blank\">positive</a> analyst action.</li><li><a href='https://seekingalpha.com/symbol/CDNA' title='CareDx'>CDNA</a> <font color='green'>+7%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3297837-premarket-analyst-action-healthcare\" target=\"_blank\">positive</a> analyst action.</li><li><a href='https://seekingalpha.com/symbol/CEMP' title='Cempra, Inc.'>CEMP</a> <font color='green'>+6%</font>.</li><li><a href='https://seekingalpha.com/symbol/MU' title='Micron Technology Inc.'>MU</a> <font color='green'>+6%</font>&nbsp;on Q4 earning <a href=\"https://seekingalpha.com/news/3297691-micron-technology-beats-0_18-beats-revenue\" target=\"_blank\">result</a>.</li><li><a href='https://seekingalpha.com/symbol/AXON' title='Axovant Sciences'>AXON</a> <font color='green'>+5%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3297871\" data-linked=\"Premarket Gainers as of 9:05 am\" data-tweet=\"$IMNPQ $MARK $AZRX - Premarket Gainers as of 9:05 am https://seekingalpha.com/news/3297871-premarket-gainers-of-9-05?source=tweet\" data-url=\"https://seekingalpha.com/news/3297871-premarket-gainers-of-9-05\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:26 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3297870\" data-ts=\"1506518756\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3297870-treasurys-tumble-10-year-yield-tops-2_30\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Treasurys tumble, 10-year yield tops 2.30%</a></h4><ul><li>The 10-year yield continues its big September rise, up another seven basis points today to 2.31% - its highest level in about two months. <a href='https://seekingalpha.com/symbol/TLT' title='iShares 20+ Year Treasury Bond ETF'>TLT</a>&nbsp;<font color='red'>-1.3%</font>, <a href='https://seekingalpha.com/symbol/TBT' title='ProShares UltraShort 20+ Year Treasury ETF'>TBT</a>&nbsp;<font color='green'>+2.6%</font></li><li>Adding to the excuses to sell was a far stronger-than-expected <a href=\"https://seekingalpha.com/news/3297833-durable-goods-reading-rises-faster-anticipated\" target=\"_blank\">durable goods report</a> (though it was August data).</li><li><a href=\"https://www.cmegroup.com/trading/interest-rates/stir/30-day-federal-fund.html\" target=\"_blank\">Short-term interest rate futures</a> are now pricing in a 100% chance of a Fed rate hike prior to year-end - odds were less than 50% just a couple of weeks ago.</li><li>ETFs: <a href='https://seekingalpha.com/symbol/TLT' title='iShares 20+ Year Treasury Bond ETF'>TLT</a>, <a href='https://seekingalpha.com/symbol/TBT' title='ProShares UltraShort 20+ Year Treasury ETF'>TBT</a>, <a href='https://seekingalpha.com/symbol/TMV' title='Direxion Daily 20+ Year Treasury Bear 3x Shares ETF'>TMV</a>, <a href='https://seekingalpha.com/symbol/TBF' title='ProShares Short 20+ Year Treasury ETF'>TBF</a>, <a href='https://seekingalpha.com/symbol/EDV' title='Vanguard Extended Duration Treasury ETF'>EDV</a>, <a href='https://seekingalpha.com/symbol/TMF' title='Direxion Daily 30-Year Treasury Bull 3x Shares ETF'>TMF</a>, <a href='https://seekingalpha.com/symbol/TTT' title='ProShares UltraPro Short 20+ Year Treasury ETF'>TTT</a>, <a href='https://seekingalpha.com/symbol/ZROZ' title='PIMCO 25+ Year Zero Coupon U.S. Treasury Index ETF'>ZROZ</a>, <a href='https://seekingalpha.com/symbol/VGLT' title='Vanguard Long-Term Government Bond Index ETF'>VGLT</a>, <a href='https://seekingalpha.com/symbol/TLH' title='iShares 10-20 Year Treasury Bond ETF'>TLH</a>, <a href='https://seekingalpha.com/symbol/UBT' title='ProShares Ultra 20+ Year Treasury ETF'>UBT</a>, <a href='https://seekingalpha.com/symbol/TLO' title='SPDR Barclays Long Term Treasury ETF'>TLO</a>, <a href='https://seekingalpha.com/symbol/DLBS' title='iPath U.S. Treasury Long Bond Bear ETN'>DLBS</a>, <a href='https://seekingalpha.com/symbol/VUSTX' title='Vanguard Long Term Treasury Fund Inv'>VUSTX</a>, <a href='https://seekingalpha.com/symbol/TYBS' title='Direxion Daily 20+ Year Treasury Bear 1x Shares ETF'>TYBS</a>, <a href='https://seekingalpha.com/symbol/DLBL' title='iPath U.S. Treasury Long Bond Bull ETN'>DLBL</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3297870\" data-linked=\"Treasurys tumble, 10-year yield tops 2.30%\" data-tweet=\"$TLT $TBT $TMV - Treasurys tumble, 10-year yield tops 2.30% https://seekingalpha.com/news/3297870-treasurys-tumble-10-year-yield-tops-2_30?source=tweet\" data-url=\"https://seekingalpha.com/news/3297870-treasurys-tumble-10-year-yield-tops-2_30\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:25 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>21&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3297869\" data-ts=\"1506518744\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/IMNP\" target=\"_blank\">IMNP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3297869-immune-pharmas-bertilimumab-shows-treatment-effect-in-mid-stage-bullous-pemphigoid-study\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Immune Pharma&#39;s bertilimumab shows treatment effect in mid-stage bullous pemphigoid study; shares up 53% premarket</a></h4><ul><li>Nano cap Immune Pharmaceuticals (<a href='https://seekingalpha.com/symbol/IMNP' title='Immune Pharmaceuticals Inc.'>OTCQB:IMNP</a>) is up&nbsp;<font color='green'>53%</font>&nbsp;premarket on robust volume in response to its <a href=\"https://seekingalpha.com/pr/16952301-immune-pharmaceuticals-announces-positive-results-ongoing-phase-2-trial-bertilimumab-bullous\" target=\"_blank\">announcement </a>of positive results from is open-label Phase 2 clinical trial assessing bertilimumab in patients with moderate-to-severe <a href=\"http://www.mayoclinic.org/diseases-conditions/bullous-pemphigoid/home/ovc-20157298\" target=\"_blank\">bullous pemphigoid</a>, a rare autoimmune skin disorder characterized by large fluid-filled blisters.</li><li>Results from three new patients confirm the findings from the first three reported in February. All six participants experienced an 85% decline from baseline in symptoms as measured by a scale called BPDAI Total Activity Score on day 84 (one subject was assessed on day 56). The mean decline was 72% by day 42 (p=0.0145). Four of the six experienced reductions greater than 90%.</li><li>Enrollment is ongoing with a target of 12 - 15. A larger study will be initiated afterward.</li><li><a href=\"http://www.immunepharma.com/products/bertilimumab/\" target=\"_blank\">Bertilimumab </a>is a monoclonal antibody that binds to pro-inflammatory protein called eotaxin-1. It is also being developed for the treatment of inflammatory bowel disease (Crohn's and colitis) and atopic dermatitis.</li></ul><div class=\"tiny-share-widget\" data-id=\"3297869\" data-linked=\"Immune Pharma&#39;s bertilimumab shows treatment effect in mid-stage bullous pemphigoid study; shares up 53% premarket\" data-tweet=\"$IMNP $IMNPQ - Immune Pharma&#39;s bertilimumab shows treatment effect in mid-stage bullous pemphigoid study; shares up 53% premarket https://seekingalpha.com/news/3297869-immune-pharmas-bertilimumab-shows-treatment-effect-in-mid-stage-bullous-pemphigoid-study?source=tweet\" data-url=\"https://seekingalpha.com/news/3297869-immune-pharmas-bertilimumab-shows-treatment-effect-in-mid-stage-bullous-pemphigoid-study\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:25 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3297866\" data-ts=\"1506518331\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SONC\" target=\"_blank\">SONC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3297866-sonic-lower-after-alarming-report-on-breach\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sonic lower after alarming report on breach</a></h4><ul> <li>The Krebs on Security blog <a href=\"https://krebsonsecurity.com/2017/09/breach-at-sonic-drive-in-may-have-impacted-millions-of-credit-debit-cards/\" target=\"_blank\">reports</a> that a breach at Sonic (NASDAQ:<a href='https://seekingalpha.com/symbol/SONC' title='Sonic Corp.'>SONC</a>) may have led to a \"fire sale\" of millions of stolen credit card and debit cards.</li> <li>Krebs posted a frightening screenshot of the proposed sale on the underground market of 5M credit/debit accounts advertised as 100% fresh. Perhaps even more alarming, financial institutions have reported a wave of fraudulent financial transactions tied to Sonic.</li> <li>SONC&nbsp;<font color='red'>-1.4%</font>&nbsp;premarket to $24.25.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3297866\" data-linked=\"Sonic lower after alarming report on breach\" data-tweet=\"$SONC - Sonic lower after alarming report on breach https://seekingalpha.com/news/3297866-sonic-lower-after-alarming-report-on-breach?source=tweet\" data-url=\"https://seekingalpha.com/news/3297866-sonic-lower-after-alarming-report-on-breach\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:18 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3297865\" data-ts=\"1506518175\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BLPH\" target=\"_blank\">BLPH</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3297865-bellerophon-secures-23_4m-private-capital-raise-shares-ahead-6-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Bellerophon secures $23.4M private capital raise; shares ahead 6% premarket</a></h4><ul><li>Thinly traded nano cap Bellerophon Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/BLPH' title='Bellerophon Therapeutics'>BLPH</a>) is up&nbsp;<font color='green'>6%</font>&nbsp;premarket on light volume in response to its <a href=\"https://seekingalpha.com/pr/16952468-bellerophon-announces-23-million-private-placement\" target=\"_blank\">agreement </a>to sell 19.4M shares of common stock and warrants to purchase 19.4M shares of common to institutional investors at a combined price of ~$1.21 (gross proceeds will be ~$23.4M).</li><li>The five-year warrants are exercisable at $1.242 per common share. Closing date is September 29.</li><li>Net proceeds will be used for general corporate purposes.</li><li>Yesterday's close was $1.08.</li></ul><div class=\"tiny-share-widget\" data-id=\"3297865\" data-linked=\"Bellerophon secures $23.4M private capital raise; shares ahead 6% premarket\" data-tweet=\"$BLPH - Bellerophon secures $23.4M private capital raise; shares ahead 6% premarket https://seekingalpha.com/news/3297865-bellerophon-secures-23_4m-private-capital-raise-shares-ahead-6-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3297865-bellerophon-secures-23_4m-private-capital-raise-shares-ahead-6-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:16 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3297863\" data-ts=\"1506517830\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3297863-premarket-losers-of-9-05\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket Losers as of 9:05 am</a></h4><ul>     <li><a href='https://seekingalpha.com/symbol/KRNT' title='Kornit Digital'>KRNT</a>&nbsp;<font color='red'>-20%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3297717-kornit-digital-lowers-revenue-guidance-shares-flat-ah\" target=\"_blank\">lowering</a> revenue guidance.</li><li><a href='https://seekingalpha.com/symbol/BW' title='Babcock & Wilcox Enterprises, Inc.'>BW</a> <font color='red'>-17%</font>&nbsp;on <a href=\"https://seekingalpha.com/pr/16952174-b-and-w-provides-update-u-k-renewable-projects\" target=\"_blank\">providing</a> update on U.K. renewable projects.</li><li><a href='https://seekingalpha.com/symbol/WLKP' title='Westlake Chemical Partners LP'>WLKP</a>&nbsp;<font color='red'>-9%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3297738-westlake-chemical-partners-buys-added-stake-westlake-opco-229m\" target=\"_blank\">acquiring</a> additional interest in Westlake Chemical OpCo.</li><li><a href='https://seekingalpha.com/symbol/IZEA' title='IZEA Worldwide, Inc.'>IZEA</a> <font color='red'>-7%</font>.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3297863\" data-linked=\"Premarket Losers as of 9:05 am\" data-tweet=\"$KRNT $BW $WLKP - Premarket Losers as of 9:05 am https://seekingalpha.com/news/3297863-premarket-losers-of-9-05?source=tweet\" data-url=\"https://seekingalpha.com/news/3297863-premarket-losers-of-9-05\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:10 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3297862\" data-ts=\"1506517779\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TRPX\" target=\"_blank\">TRPX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3297862-therapixs-low-dose-thc-drug-candidate-reverses-age-related-cognitive-impairment-in-animal\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Therapix&#39;s low-dose THC drug candidate reverses age-related cognitive impairment in animal study; shares ahead 11% premarket</a></h4><ul><li>Thinly traded nano cap Therapix Biosciences (NASDAQ:<a href='https://seekingalpha.com/symbol/TRPX' title='Therapix Biosciences'>TRPX</a>) is up&nbsp;<font color='green'>11%</font>&nbsp;premarket on modestly higher volume in response to its <a href=\"https://seekingalpha.com/pr/16952457-therapixs-first-class-therapy-demonstrates-reversal-age-related-cognitive-impairment-pre\" target=\"_blank\">announcement </a>of positive preclinical results on Mild Cognitive Impairment &#40;MCI&#41;&nbsp;candidate THX-ULD01, its ultra-low dose tetrahydrocannabinol &#40;THC&#41; drug.</li><li>In a study conducted in Israel, old mice treated with THX-ULD01 showed significant reversals in age-related cognitive impairment. The benefit from one injection of 0.002 mg/kg of THC lasted for at least seven weeks.</li><li>The company is developing the drug for sublingual or nasal administration.</li><li>The data will be presented at the International Association for Cannabinoid Medicines 9th Conference on Cannabinoids in Medicine in Cologne, Germany later this week.</li></ul><div class=\"tiny-share-widget\" data-id=\"3297862\" data-linked=\"Therapix&#39;s low-dose THC drug candidate reverses age-related cognitive impairment in animal study; shares ahead 11% premarket\" data-tweet=\"$TRPX - Therapix&#39;s low-dose THC drug candidate reverses age-related cognitive impairment in animal study; shares ahead 11% premarket https://seekingalpha.com/news/3297862-therapixs-low-dose-thc-drug-candidate-reverses-age-related-cognitive-impairment-in-animal?source=tweet\" data-url=\"https://seekingalpha.com/news/3297862-therapixs-low-dose-thc-drug-candidate-reverses-age-related-cognitive-impairment-in-animal\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:09 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3297858\" data-ts=\"1506517573\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TRVG\" target=\"_blank\">TRVG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3297858-jpmorgan-downgrades-trivago\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">JPMorgan downgrades Trivago</a></h4><ul><li>        JPMorgan <a href=\"https://www.streetinsider.com/Analyst+Comments/JPMorgan+Downgrades+trivago+N.V.+%28TRVG%29+to+Neutral/13331541.html\" target=\"_blank\">downgrades</a> Trivago (NASDAQ:<a href='https://seekingalpha.com/symbol/TRVG' title='Trivago'>TRVG</a>) from Overweight to Neutral and cuts the price target by $2 to $14.</li><li>               Analyst Doug Anmuth says the company carries risks and the planned turnaround will take time as the company works out bid process adjustments from large advertisers and reveals its new attribution model.&nbsp;</li><li>               Trivago shares are&nbsp;<font color='red'>down 3.21%&nbsp;</font>premarket.&nbsp;&nbsp;</li><li>Previously: <a href=\"https://seekingalpha.com/news/3293822-online-travel-sector-retreat-trivago-warning\" target=\"_blank\">Online travel sector in retreat after Trivago warning</a> (Sept. 6)</li></ul><div class=\"tiny-share-widget\" data-id=\"3297858\" data-linked=\"JPMorgan downgrades Trivago\" data-tweet=\"$TRVG - JPMorgan downgrades Trivago https://seekingalpha.com/news/3297858-jpmorgan-downgrades-trivago?source=tweet\" data-url=\"https://seekingalpha.com/news/3297858-jpmorgan-downgrades-trivago\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:06 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3297846\" data-ts=\"1506516618\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MU\" target=\"_blank\">MU</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3297846-analysts-raise-micron-technology-price-targets-after-earnings\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Analysts raise Micron Technology price targets after earnings</a></h4><ul><li>Analysts adjust price targets after Micron Technology&rsquo;s (NASDAQ:<a href='https://seekingalpha.com/symbol/MU' title='Micron Technology Inc.'>MU</a>) Q4 beats yesterday.</li><li>Wells Fargo <a href=\"https://www.streetinsider.com/Analyst+EPS+Change/Micron+Technology+%28MU%29%3A+Strong+Rev+and+GM+Momentum%2C+PT+To+%2445+-+Wells+Fargo/13332528.html\" target=\"_blank\">raises</a> its Micron price target by $5 to $45 and maintains an Outperform rating.</li><li>Analyst David Wong introduces an FY19 GAAP EPS estimate of $5.60. The figure is below the FY18 estimate but Wong says that if the &ldquo;positive memory pricing environment continues&rdquo; the firm could raise that FY19 estimate</li><li>Baird <a href=\"https://www.streetinsider.com/Analyst+Comments/Micron+Technology+%28MU%29+PT+Raised+to+%2452+at+Baird/13331947.html\" target=\"_blank\">raises</a> its price target from $48 to $52 and maintains an Outperform rating.</li><li>Analyst Tristan Gerra believes in the supply-demand trends for Micron in FY18 are sustainable especially for DRAM.</li><li>Finally Susquehanna <a href=\"https://www.streetinsider.com/Analyst+Comments/Micron+Technology+%28MU%29+PT+Raised+to+%2454+at+Susquehanna/13331933.html\" target=\"_blank\">raises</a> its Micron price target by $4 to $54 and maintains a Positive rating.</li><li>Micron shares are&nbsp;<font color='green'>up 5.53%&nbsp;</font>premarket.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3297722-micron-technology-plus-2-percent-q4-guidance-beats-strong-dram-nand\" target=\"_blank\">Micron Technology +2% after Q4, guidance beats on strong DRAM and NAND</a> (Sept. 26)</li><li>Update: Bloomberg Intelligence analyst Anand Srinivasan calls the demand for memory a \"utopia\" scenario particularly in DRAM, which could drive Micron's sales and margins through next year.</li></ul><div class=\"tiny-share-widget\" data-id=\"3297846\" data-linked=\"Analysts raise Micron Technology price targets after earnings\" data-tweet=\"$MU - Analysts raise Micron Technology price targets after earnings https://seekingalpha.com/news/3297846-analysts-raise-micron-technology-price-targets-after-earnings?source=tweet\" data-url=\"https://seekingalpha.com/news/3297846-analysts-raise-micron-technology-price-targets-after-earnings\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:50 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>66&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3297841\" data-ts=\"1506516133\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LXRX\" target=\"_blank\">LXRX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3297841-lexicon-pharma-launches-early-stage-study-of-neuropathic-pain-candidate-lx9211-shares-ahead-3\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Lexicon Pharma launches early-stage study of neuropathic pain candidate LX9211; shares ahead 3% premarket</a></h4><ul><li>Lexicon Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/LXRX' title='Lexicon Pharmaceuticals, Inc.'>LXRX</a>) perks up&nbsp;<font color='green'>3%&nbsp;</font>premarket on light volume in response to its <a href=\"https://seekingalpha.com/pr/16952216-lexicon-pharmaceuticals-initiates-patient-dosing-phase-1-study-lx9211\" target=\"_blank\">announcement </a>that dosing has begun in a Phase 1 clinical trial assessing small molecule LX9211, a candidate for the treatment of neuropathic pain.</li><li>The single ascending dose study will assess the safety, tolerability and pharmacokinetics of LX9211 across nine oral escalating doses (5 mg to 300 mg) in healthy volunteers.</li><li>Lexicon acquired the exclusive rights to the candidate from development partner Bristol-Myers Squibb in November 2016. BMY will earn development-, regulatory- and sales-based milestones in addition to royalties on net sales.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3221726-lexicon-pharma-nabs-rights-neuropathic-pain-candidate-jointly-developed-bristol-myers-squibb\" target=\"_blank\">Lexicon Pharma nabs rights to neuropathic pain candidate jointly developed with Bristol-Myers Squibb</a> (Nov. 7, 2016)</li></ul><div class=\"tiny-share-widget\" data-id=\"3297841\" data-linked=\"Lexicon Pharma launches early-stage study of neuropathic pain candidate LX9211; shares ahead 3% premarket\" data-tweet=\"$LXRX - Lexicon Pharma launches early-stage study of neuropathic pain candidate LX9211; shares ahead 3% premarket https://seekingalpha.com/news/3297841-lexicon-pharma-launches-early-stage-study-of-neuropathic-pain-candidate-lx9211-shares-ahead-3?source=tweet\" data-url=\"https://seekingalpha.com/news/3297841-lexicon-pharma-launches-early-stage-study-of-neuropathic-pain-candidate-lx9211-shares-ahead-3\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:42 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3297830\" data-ts=\"1506515221\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AMD\" target=\"_blank\">AMD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3297830-digitimes-amd-launching-new-ryzen-processors-in-february\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Digitimes: AMD launching new Ryzen processors in February</a></h4><ul><li>        Advanced Micro Devices (NASDAQ:<a href='https://seekingalpha.com/symbol/AMD' title='Advanced Micro Devices, Inc.'>AMD</a>) tells motherboard manufacturing partners that it plans to launch a 12nm upgrade version of its Ryzen processors in February 2018, according to <a href=\"http://www.digitimes.com/news/a20170927PD212.html\" target=\"_blank\">Digitimes</a> sources.</li><li>               The company will first release CPUs codenamed Pinnacle 7 with a mid-range Pinnacle 5 and budget-friendly Pinnacle 3 following in March. A low-power version will arrive the next month with an enterprise version coming in May.&nbsp;</li><li>               The 400-series chipsets corresponding to the processors will become available in March.&nbsp;</li><li>               GlobalFoundries will produce the Ryzen processors using 12nm low-power process technology. &nbsp;&nbsp;</li><li>               AMD shares are&nbsp;<font color='green'>up 1.61%</font>&nbsp;premarket.&nbsp;&nbsp;&nbsp;&nbsp;</li></ul><div class=\"tiny-share-widget\" data-id=\"3297830\" data-linked=\"Digitimes: AMD launching new Ryzen processors in February\" data-tweet=\"$AMD - Digitimes: AMD launching new Ryzen processors in February https://seekingalpha.com/news/3297830-digitimes-amd-launching-new-ryzen-processors-in-february?source=tweet\" data-url=\"https://seekingalpha.com/news/3297830-digitimes-amd-launching-new-ryzen-processors-in-february\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:27 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>148&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3297827\" data-ts=\"1506515152\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ASND\" target=\"_blank\">ASND</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3297827-ascendis-pharma-s-prices-public-offering-of-adss-shares-off-2-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ascendis Pharma A/S prices public offering of ADSs; shares off 2% premarket</a></h4><ul> <li>Ascendis Pharma A/S (NASDAQ:<a href='https://seekingalpha.com/symbol/ASND' title='Ascendis Pharma'>ASND</a>) <a href=\"https://seekingalpha.com/pr/16952041-ascendis-pharma-s-announces-pricing-public-offering-adss\" target=\"_blank\">prices</a> its public offering of 3.8M ADSs, each ADS representing one ordinary share, at a price of&nbsp;$35.50&nbsp;per ADS.</li><li>Underwriters over-allotment is an additional&nbsp;570,000 ADSs.</li><li>Closing date is September 29.</li>   <li>Net proceeds of ~$126.1M will be used to support clinical development and commercialization of TransCon product candidates, working capital and general corporate purposes.</li><li>Shares are down&nbsp;<font color='red'>2%</font>&nbsp;premarket on light volume. Yesterday's close was $37.10.</li>    </ul><div class=\"tiny-share-widget\" data-id=\"3297827\" data-linked=\"Ascendis Pharma A/S prices public offering of ADSs; shares off 2% premarket\" data-tweet=\"$ASND - Ascendis Pharma A/S prices public offering of ADSs; shares off 2% premarket https://seekingalpha.com/news/3297827-ascendis-pharma-s-prices-public-offering-of-adss-shares-off-2-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3297827-ascendis-pharma-s-prices-public-offering-of-adss-shares-off-2-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:25 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3297820\" data-ts=\"1506515134\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ZSAN\" target=\"_blank\">ZSAN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3297820-zosano-provides-patent-application-update-shares-ahead-9-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Zosano provides patent application update; shares ahead 9% premarket</a></h4><ul> <li>Zosano Pharma (NASDAQ:<a href='https://seekingalpha.com/symbol/ZSAN' title='Zosano Pharma'>ZSAN</a>) <a href=\"https://seekingalpha.com/pr/16951937-zosano-provides-patent-application-update\" target=\"_blank\">receives</a> official written notification of an Office action from the U.S. Patent and Trademark Office &#40;USPTO&#41; regarding its patent application 15/438,455 &ldquo;Method of rapidly achieving therapeutic concentrations of triptans for treatment of migraines\" related to lead candidat M207.&nbsp;&nbsp;<em>&nbsp;</em></li>       <li>The outcome of these ongoing discussions remains uncertain.&nbsp;The Company may not be able to address the questions raised by the USPTO and therefore the patent application may not be issued in its current form or in revised version.</li><li>The new patent, if issued, will extend protection through 2037. Its existing patent, U.S. No. 9,421,351, covers M207 through 2027.</li>      <li>Shares are up&nbsp;<font color='green'>9%</font>&nbsp;premarket on light volume.</li>            </ul><div class=\"tiny-share-widget\" data-id=\"3297820\" data-linked=\"Zosano provides patent application update; shares ahead 9% premarket\" data-tweet=\"$ZSAN - Zosano provides patent application update; shares ahead 9% premarket https://seekingalpha.com/news/3297820-zosano-provides-patent-application-update-shares-ahead-9-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3297820-zosano-provides-patent-application-update-shares-ahead-9-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:25 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3297823\" data-ts=\"1506514554\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RH\" target=\"_blank\">RH</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3297823-insider-buying-rh\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Insider buying at RH</a></h4><ul> <li>RH (NYSE:<a href='https://seekingalpha.com/symbol/RH' title='RH'>RH</a>) discloses that Chairman and CEO Gary Friedman picked up 13,959 shares at an average price of $71.64 per share.</li> <li>Friedman acquired the shares yesterday. He now holds 2.235M shares.</li> <li><a href=\"https://seekingalpha.com/filing/3707111\" target=\"_blank\">SEC Form 4</a></li> <li>Shares of RH fell 3.16% yesterday, but&nbsp;<font color='green'>jumped 1.57%</font>&nbsp;in after-hours trading after the insider buying was reported.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3297823\" data-linked=\"Insider buying at RH\" data-tweet=\"$RH - Insider buying at RH https://seekingalpha.com/news/3297823-insider-buying-rh?source=tweet\" data-url=\"https://seekingalpha.com/news/3297823-insider-buying-rh\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:15 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>13&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3297822\" data-ts=\"1506514539\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CASC\" target=\"_blank\">CASC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3297822-cascadians-tucatinib-orphan-drug-in-u-s-for-her2-crc-shares-ahead-7-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cascadian&#39;s tucatinib an Orphan Drug in U.S. for HER2+ CRC; shares ahead 7% premarket</a></h4><ul><li>Thinly traded micro cap Cascadian Therapeutics (NYSE:<a href='https://seekingalpha.com/symbol/CASC' title='Cascadian Therapeutics, Inc'>CASC</a>) is up&nbsp;<font color='green'>7%</font>&nbsp;premarket on increased volume in response to its <a href=\"https://seekingalpha.com/pr/16952195-cascadian-therapeutics-announces-fda-orphan-drug-designation-granted-tucatinib-treatment-her2\" target=\"_blank\">announcement </a>that the FDA has granted Orphan Drug status for Phase 2-stage tucatinib for the treatment of patients with HER2-positive metastatic colorectal cancer &#40;CRC&#41;.</li><li>The primary endpoint of the Phase 2 study, <a href=\"https://clinicaltrials.gov/ct2/show/NCT03043313?term=nct03043313&amp;recrs=ab&amp;rank=1\" target=\"_blank\">MOUNTAINEER</a>, is objective response rate. According to ClinicalTrials.gov, the estimated primary completion date is June 2019.</li><li>Tucatinib is a tyrosine kinase inhibitor that is highly selective for HER2 without significantly inhibiting EGFR which causes unwanted side effects.</li></ul><div class=\"tiny-share-widget\" data-id=\"3297822\" data-linked=\"Cascadian&#39;s tucatinib an Orphan Drug in U.S. for HER2+ CRC; shares ahead 7% premarket\" data-tweet=\"$CASC - Cascadian&#39;s tucatinib an Orphan Drug in U.S. for HER2+ CRC; shares ahead 7% premarket https://seekingalpha.com/news/3297822-cascadians-tucatinib-orphan-drug-in-u-s-for-her2-crc-shares-ahead-7-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3297822-cascadians-tucatinib-orphan-drug-in-u-s-for-her2-crc-shares-ahead-7-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:15 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3297815\" data-ts=\"1506513700\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TWLO\" target=\"_blank\">TWLO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3297815-mufg-analyst-says-buy-twilio-on-selloff\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">MUFG analyst says buy Twilio on selloff</a></h4><ul><li>        MUFG Securities analyst Stephen Bersey advises clients to buy Twilio (NYSE:<a href='https://seekingalpha.com/symbol/TWLO' title='Twilio'>TWLO</a>) on the selloff happening since Amazon announced its new two-way text messaging service.</li><li>               Bersey sees Amazon&rsquo;s announcement as a broadening of its partnership with Twilio rather than direct competition.&nbsp;</li><li>               MUFG rates Twilio at Overweight with a $35 price target.&nbsp;</li><li>               Source: Bloomberg First Word&nbsp;</li><li>               Twilio shares are&nbsp;<font color='green'>up 5.38%</font>&nbsp;premarket.&nbsp;&nbsp;</li><li>Previously: <a href=\"https://seekingalpha.com/news/3297695-twilio-drops-amazon-announces-aws-two-way-texting\" target=\"_blank\">Twilio drops after Amazon announces AWS two-way texting</a> (Sept. 26)</li></ul><div class=\"tiny-share-widget\" data-id=\"3297815\" data-linked=\"MUFG analyst says buy Twilio on selloff\" data-tweet=\"$TWLO - MUFG analyst says buy Twilio on selloff https://seekingalpha.com/news/3297815-mufg-analyst-says-buy-twilio-on-selloff?source=tweet\" data-url=\"https://seekingalpha.com/news/3297815-mufg-analyst-says-buy-twilio-on-selloff\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:01 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3297809\" data-ts=\"1506513447\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SN\" target=\"_blank\">SN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3297809-sanchez-energy-reiterates-q4-production-outlook\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sanchez Energy reiterates Q4 production outlook</a></h4><ul>     <li>Sanchez Energy (NYSE:<a href='https://seekingalpha.com/symbol/SN' title='Sanchez Energy Corporation'>SN</a>) <font color='green'>+3.3%</font> premarket after reporting <a href=\"https://seekingalpha.com/pr/16951991-sanchez-energy-announces-strong-catarina-well-results-reiterates-fourth-quarter-2017\" target=\"_blank\">strong Catarina well results</a> and reiterating Q4 production guidance.</li>     <li>SN says the six Western Catarina wells recently brought online are outperforming type curve projections by ~20%, which should allow the potential extension of the development further eastward.</li>     <li>Despite the temporary suspension of completion  operations due to Hurricane Harvey, SN reiterates Q4 production guidance of 80K-84K boe/day, citing strong well results in the western Eagle Ford.</li></ul><div class=\"tiny-share-widget\" data-id=\"3297809\" data-linked=\"Sanchez Energy reiterates Q4 production outlook\" data-tweet=\"$SN $SNEC - Sanchez Energy reiterates Q4 production outlook https://seekingalpha.com/news/3297809-sanchez-energy-reiterates-q4-production-outlook?source=tweet\" data-url=\"https://seekingalpha.com/news/3297809-sanchez-energy-reiterates-q4-production-outlook\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:57 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3297801\" data-ts=\"1506512726\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CTLT\" target=\"_blank\">CTLT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3297801-catalent-prices-public-offering-of-common-stock-to-fund-acquisition-of-cook-pharmica-shares\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Catalent prices public offering of common stock to fund its acquisition of Cook Pharmica; shares ahead 2% premarket</a></h4><ul> <li>Catalent (NYSE:<a href='https://seekingalpha.com/symbol/CTLT' title='Catalent'>CTLT</a>) <a href=\"https://seekingalpha.com/pr/16952019-catalent-inc-announces-pricing-public-offering-common-stock-fund-part-acquisition-cook\" target=\"_blank\">prices</a> its public offering of 6.4M shares of common stock at $39.10 per share. Underwriters over-allotment is an additional&nbsp;959,250&nbsp;shares.</li><li>Closing date is&nbsp;September 29.</li><li>Net proceeds of ~$242.2M will help fund the Cook Pharmica deal.</li>     <li>Shares are up&nbsp;<font color='green'>2%</font>&nbsp;premarket on modest volume. Yesterday's close was $39.21.</li>     </ul><div class=\"tiny-share-widget\" data-id=\"3297801\" data-linked=\"Catalent prices public offering of common stock to fund its acquisition of Cook Pharmica; shares ahead 2% premarket\" data-tweet=\"$CTLT - Catalent prices public offering of common stock to fund its acquisition of Cook Pharmica; shares ahead 2% premarket https://seekingalpha.com/news/3297801-catalent-prices-public-offering-of-common-stock-to-fund-acquisition-of-cook-pharmica-shares?source=tweet\" data-url=\"https://seekingalpha.com/news/3297801-catalent-prices-public-offering-of-common-stock-to-fund-acquisition-of-cook-pharmica-shares\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:45 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3297797\" data-ts=\"1506511669\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LCI\" target=\"_blank\">LCI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3297797-lannett-receives-fda-approval-for-oxycodone-and-acetaminophen-tablets-usp-5-and-10-mg-325-mg\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Lannett receives FDA approval for Oxycodone and Acetaminophen tablets USP, 5 and 10 mg/325 mg</a></h4><ul> <li>FDA has <a href=\"https://seekingalpha.com/pr/16952172-lannett-receives-fda-approval-oxycodone-acetaminophen-tablets-usp-5-mg-325-mg-10-mg-325-mg\" target=\"_blank\">approved</a> Lannett Company's (NYSEMKT:<a href='https://seekingalpha.com/symbol/LCI' title='Lannett Company, Inc'>LCI</a>) Abbreviated New Drug Application for Oxycodone and Acetaminophen Tablets, USP, 5 mg/325 mg and 10 mg/325 mg, the therapeutic equivalent to Percocet&nbsp;Tablets, 5 mg/325 mg and 10 mg/325 mg, of Vintage Pharmaceuticals.</li><li>According to IMS,&nbsp;total&nbsp;U.S.&nbsp;sales of Oxycodone and Acetaminophen tablets&nbsp;were ~$571M for the year ended July.</li><li>Shares are up&nbsp;<font color='green'>1%</font>&nbsp;premarket on light volume.</li>                   </ul><div class=\"tiny-share-widget\" data-id=\"3297797\" data-linked=\"Lannett receives FDA approval for Oxycodone and Acetaminophen tablets USP, 5 and 10 mg/325 mg\" data-tweet=\"$LCI - Lannett receives FDA approval for Oxycodone and Acetaminophen tablets USP, 5 and 10 mg/325 mg https://seekingalpha.com/news/3297797-lannett-receives-fda-approval-for-oxycodone-and-acetaminophen-tablets-usp-5-and-10-mg-325-mg?source=tweet\" data-url=\"https://seekingalpha.com/news/3297797-lannett-receives-fda-approval-for-oxycodone-and-acetaminophen-tablets-usp-5-and-10-mg-325-mg\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:27 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li>","count":74,"message":null,"success":true,"today":{"start":1577077200,"end":1577163599,"str":"Monday, December 23, 2019"},"yesterday":{"start":1576990800,"end":1577077199}}